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A B  TRACT 
The emergence and g loba l spread of carbapenem resistant 
Enterobacteriaceae i an a lann ing world-wide phenomenon that a l so affects the 
Midd le  Ea t due to l im ited treatment option for such infections and their 
common a ociation w ith h igh leve l  of fata l ity . The most important mechan ism of 
uch resistance is caused by the production of variou carbapenemase enzymes. I n  
the Arabian Peninsu la, s o  far, N D M  and OXA48-l ike carbapenemases have been 
reported, whi le e l se\ here other enzymes, e.g. V IM,  I MP and KPC are a lso 
commonl found. Our a im was to systematica l ly look for the V I M-type 
carbapenemases among loca l  iso lates and to characterize their genetic 
background. 
In i t ia l ly, screening isolates from Abu Dhabi hospita l s  we identified a s ingle 
Enterobacter cloaceae stra in  carrying the V IM-4 a l le le. This was the first such 
isolate ever reported from the Peninsula .  Subsequently, investigating isolates from 
Kuwait, Saudi A rabia, Oman and the UAE, we ident ified a further 1 1  isolates, one 
E. cloaceae from Saudi Arabia, two from Oman, one from Kuwa it and a l so one 
E cherichia coli from this country. Besides these, the latter country a lso provided 
s ix Klebsiella pneumoniae isolates. A l l  stra ins produced the VJM-4 variant of the 
enzyme as determ ined by the sequencing of their  genes. I n  a l l  cases, the gene was 
located on p lasmids of varying sizes, e ither non-typable or belonging to the 
lncAiC group; most of them were conj ugat ive and they commonly harbored other 
13-lactamase genes, such as CTX-M or CMY -4. In a l l  strains the V IM -4 gene was 
located w ithin a c lass I integron - with some variations between the gene casettes 
present - s imi lar to stra ins previously identified in  North Africa and I ta ly, 
- vi i -
sugge t ing the po ib i l ity of spread. Clonal typing re ealed that the re latively high 
inc idence of V I M-producer Enterobacteriaceae encountered i n  Kuv.ait  was not 
due to the spread of a part icu lar c lone, but most probably was the result of the 
tran fer of an I nc C pIa mid,  co-harboring blavIM4 and blacMY-4. into Klebsiella 
pneumoniae and E. coli. 
Our data show that, beyond NDM and OXA-48-l ike, V I M  type carbapenemases 
are the third most common iso lates in the Arabian Pen insula .  Further invest igation 
i needed to moni tor the spread of c lones and genes in the region. 
- vi i i  -
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F I G URE 1 5. blavrM-4 bearing class I i ntegrons of Enterobacteriaceae from the 















C H L  
crp 













E R IC 
ERT 




G M  
I DSA 










Centers for Di  ease Control and Prevention 
Cifrobacter/re lIndii 
olony forming unit  
Ch loramphen icol 
C iprofloxac in 
C l in ica l  and Laboratory Standards I nstitute 
Col ist in 
Continued 
Carbapenem Resistant Enterobacteriaceae 
Cefotaxim 
Cefotaximase 
Deoxyribonuc leic ac id 
Deoxynuc leoside triphosphates 
Escherichia coli 
Enterobacter cloacae 
Enteroaggregative E. coli 
Ethylened iaminetetraacetic ac id 
Enteropathogenic E. coli 
Enterobacteriaceae Repetitive Intergenic  Consensus 
Ertapenem 
E tended spectrum beta- lactamase 
Eth idium Bromide 
Enterotoxigen ic E. coli 
Extraintestinal pathogenic E. coli 
Gentamic in 











M L  T 
m RN 
M IC 
M R  A 
AG 


























Ki loba e pai r  
Kleb iella pnelinJoniae carbapenmase 
L ip  poly accharide 
Mu lt i -d rug res i  tance 
Meropenem 
Modified Hodge te t 
M inimum inhibitory concentration 
M u lt i - locus equence typ ing 
Messenger Ribonuc leic ac id 
M in imum inhib itory concentrat ion 
Meth ic i  I I in-resistance Staphylococcus aureus 
-ace tyl glucosam i ne 
-acetylmuramic acid 
ew De lh i  meta J Io-beta- lactamase 
Outer mem brane 
Outer membrane prote in 
Ol igosaccharide 
Oxac i l l i nase 
Pheny lboronic acid 
Pen ic i l l in binding Prote ins 
Polymerase chain reaction 
Pulsed fie ld ge l e lectrophoresis 




Quinolone efflux pump 
Quinolone resistance determinig regions 
Rec ip ient 
Ribosomal ribonuc leic ac id 
Revol utions per minute 
Room Tempreture 
Secreted outotransporter toxin 
Sal ine Sodium c itrate 
Sod ium dodecyl su lfate 
Serratia marcescens 
Serine 
Sulfhydryl reagent variable enzyme 
- xviii -
spp. 
/3- lactama e 











T A  
T B 
U PGMA 
U T I  
U V  







u l famethoxazole 
Tran conjugants 
Tri lEOTA buffer 
Tri IBoratelEDTA 
Tran fonnants 
Tigec c l ine 
Tetracyc Jjn 
Tobramyc in 
Tryptic 0 agar 
Tryptic oy broth 
Um eighted Pair Group Method with Arithmetic Mean 
Urinary tract infection 
U ltraviolet 
Verona integron-encoded meta l lo-�-lactamase 
World Health Organ ization 
- x ix -
VIM-type carbapenemases Nour Yahfoufi, 201 4 
. . . .. .... . . . . . .. .. . . . .. . .. . . . . . . . . . ... . . .. . . .. . .. . . . . . . .. . . ... . . . . .. . . . . . . . ....... . .... . ....... ....... . . . . . . .. . . . . . . . ..... . . . . . . . .  
I. INTRODUCTION 
1. 1. Enterobacteriaceae 
The Enterobacteriaceae i s  the largest fami ly of medical ly important 
G ram-negative bacteria. Currently, it inc ludes 44 genera and 1 76 named spec ies 
(Baum ler et a ! .  20 l 3) .  Enterobacteriaceae are ubiqu itous organ isms found not 
only in animals and humans but a lso in water, soi l  and plants. These organisms 
are inhab itant of the intestinal  flora of most animals including humans (Murray 
et a 1 . 2005, Pham et a l .  2007).  
1 .1. 1. P hysiology and Cell Struct u re 
The average size of an Enterobacteriaceae cel l is between 0.3 to 1 .0 x 1 .0 
to 6 .0 �m. They are Gram-negative, non-spare-form ing bac i l l i .  They are 
facu ltative anaerobes and under optimal conditions most representatives have a 
generation time of 20-30 m in  (Wi lks et a l .  2003, Murray et a l .  2005). As typica l 
Gram negative bacteria, the envelop of Enterobacteriaceae consists of an i nner 
and an outer membrane w ith a perip lasmic space in between (FIGURE 1.). The 
outer leaflet of the outer membrane is the major cel l  wal l  (0) antigen of 
Enterobacteriaceae, i .e. the heat-stable l i popolysaccharide ( LPS) (Azari et a ! .  
20 1 3) (Murray et  a l .  2005). The outer membrane a l so contains proteins. Some are 
important l igands, some have sensor/signal ing functions, whi le  others ( i .e. porins) 
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1.1.2. Path oge nic Potent ia l  
With con iderable variation between spec ies and even between strains 
regarding their actua l v i ru lence, some members of the fami ly are considered 
genuine enteric pathogen (e.g. Salmol/ella, Shigella, the d iarrhea-causing E. coli 
pathotype ) .  orne other may colon ize the gut  as part of the microbiota, but  when 
gett ing to other, mostl e traintestinal body sites, they may cause serious, often 
l i fe-threaten ing infections (e.g. E. coli. Klebsiella). Obvious ly, these i nfections are 
even more erious in ho ts with compromised defense capac it ies. Final ly, there 
are members of the fam i ly which are c learly opportunistic pathogens, i .e .  usua l ly 
not affect ing the otherwise healthy hosts (e.g. Serratia, Enterobacter) (Holst 
2007, ordmann et a! .  20 1 2) .  
Depend ing on the site of infection, the diseases caused vary from cyst it is  
to pyelonephritis, enteri t is  sept icemia, pneumonia, peritonit is, meningitis and 
device-assoc iated infections. Thus, Enterobacteriaceae can affect practical ly  any 
body s ites. (Nordmann et al .  2012). They are responsib le for more than 70% of 
ur inary tract infections (UTI ), 30% to 35% of a l l  bacteremia, and several 
i ntest ina l  infect ions (Murray et a l .  2005). As some members a lso infect animals, 
or are carried by them, they cause zoonotic infections (most Salmonella serovars 
and Yersinia species). Others are strict human pathogens (Shigella species and S. 
Typhi) .  Among E. coli infections examples of both zoonotic transmission (e.g. 
enterohaemorrhagic E. coli) and strictly human sources (e.g. enterotoxigenic or 
enteroinvasive E. coli) can be found (Nataro and Kaper 1 998, Murray et a l .  2005). 
Enterobacteriaceae spread eas i ly between individuals either by direct contact 
- 3 -
VIM-type carbapenemases Nour Yahfoufi, 2014 
........ .......... ................ . . . . .. .............. . . .......... . ........... . ... . . . . . .............. . . .. . ......... ..... . ...... . . . 
tran mission, with the aid of contaminated fomites, or by contaminated food and 
'Water ( Baron 1 996). 
I mportantly, ome even some potential ly pathogenic members of the 
Enterobacferiaceae fami l  ( uch as E cherichia coli, Klebsiella pneumoniae, and 
Proteus mirabili ), are part of the commensal flora and co-habit the gut with 
hundreds of other member of the microbiota. Th is  fact, combined with the ease 
\\ i th which these trains are capable of acquiring genetic material through 
horizonta l gene transfer exp lains the extreme flexib i l i ty of some fami ly members 
leading to their high ly versati le pathogenic and res istant features (Partridge 20 1 1 , 
toke and G i l l ing 20 1 1 , ordmann et a ! .  20 1 2) .  
1.2. The G lobal Problem of Ant ibiot ic Resistance 
A ntibiotic resistance is  considered as one of the most pressing problems of 
contemporary medic ine. I t  has emerged as one of the foremost publ ic hea l th 
concerns of the 2 1  st century as organ isms are able to develop resistance rapid ly to 
any antib iotics introduced (van Duin et a 1 .  20 1 3) .  Antib iotic resistance threatens 
the contro l  of infectious d iseases, i ncreases morbid ity and mortal ity and imposes 
enormous costs on societies. In the European Union, about 25000 patients die 
each year from infections caused by selected mul tidrug res istant (MDR) bacteria 
and 1 .5 bil l ion euros are the annual estimated assoc iated costs ( Leung et a1 .  20 1 1 ) . 
L ikewise the I n fectious Diseases Society of America ( I DSA) considers 
ant im icrobial resistance as "one of the greatest threats to human heal th 
worldwide" and the annual  additiona l  costs of infections in the USA caused by 
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form channel through \\ hi h v arious compound . among other orne anti biotic . 
reach the inner tru ture of the cell ( Azari et a l .  20 1 3 ). 
Be) ond the omatic 0 pol) accharide antigen, other surface antigen may 
or ma) not be pre ent on the tra ins .  Cetta in Enterohacteriaceae hav e not iceable 
cap ule (K ant igen) such a Klebsiella. Enlerobacter and Escherichia strai ns, 
"h i le  other are urrounded b) a loose s l ime la  er, or noth ing at  a l l .  Depending 
on the genus,  spec ie ilnd strain they can be mot i le, with peritrichous flagel lae 
repre enting the H antigen . Whi le  the 0 antigen determines the serogroup, this 
combi ned \.\ ith the H (and somet ime '" ith the K) antigen describes the serotype 
orthe i alate. 
Flogello lH ""Iogen) � Cops.ule (t< or v, antigen) 
/ r Lpopoly>occhonde ILPS) 0' 
���t§��� 
endotoxin 






F I G U R E  1. Cel l  \\ a l l  structure of Enterobacteriaceae (Murray et a l .  2005) 
Severa l Enterobacteriaceae have fi mbriae or p i l i  assoc iated with the 
capacit) of the stra in to adhere to arious surfaces (Whitfield 1 995, Weissman et 
a l .  2003. H olst 2007) .  
------- --------------------------------------------------------------------------------------------
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re i tant organ i m ,a compared to su cept ib le organi  ms, are estimated ben een 
2 1  b i l l ion and 34 bi llion re pecti el) ( pel lberg et a l .  20 1 1 ) . 
Therefore, antimicrobial res i tance has been the foc us of the World Health 
Organization for everal ear: in 1 998, the World Health Assembly implemented 
a re olution urging member tates to take action aga inst it. In 200 1 ,  the W HO 
outl ined a global strategy on containment of ant imicrobial res istance besides a 
number of recommendations. I n  2005, a new World Health Assembly resolution 
on antim icrobial resistance was implemented, a warning about the s low progress 
\: a issued and the rat ional use of antimicrobial agents by providers and 
con umers wa cal led for. Finally in 20 1 1 ,  antim icrobia l  resistance was the focus 
of the 20 1 1 World H ea lth Day of the World Hea lth Organization (WHO) ( Leung 
et al .  20 1 1 ). 
While the problem of drug resistance affects almost all genera of 
pathogenic bacteria, the magnitude of the problem is  not the same for G ram­
posit ive and for Gram-negative bacteria. For the former group there are potent 
a l ternati es once a stra in  develops resistance to beta-lactams or even to 
vancomyc in .  However, for the latter group no such s imi larly effective, second l i ne 
treatment is available. Actual ly, new anti-Gram-negat ive antibiotics, represent ing 
completel y  new c l asses are not even i n  the development/production p ipel ines and 
are un l ikely to be avai lable in the foreseeab le future. Furthermore, res istance to 
the less-effic ient or more toxic a lternatives are emerging, result ing in pan-res istant 
stra ins (Stokes and G i l l ings 20 1 1 ,  Toleman and Walsh 20 1 1 , Zhanel et a 1 .  20 1 1 ,  
Walsh and Toleman 20 1 2, van Duin et a 1 .  20 l 3) .  
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1.2 . 1. E 'tended pectrum Beta-Lactam Re i tance Among Gram- egative 
Rod in tbe Arabian Pen i n  uJa 
The Middle Ea t, spec i fical l  the rabian Pen insu la, has not been spared 
the prob lem of drug re i tance, ei ther. I t  is not urpris ing as actually some of these 
countries can be considered extremel vulnerable to the problem . They are 
urrounded by region (the Ind ian subcontinent, North Africa etc . )  often fac ing an 
e tremel high rate of re istance. I n  some of the countries the rate of expatriate 
r ident may reach 80%, mostly coming from these areas. Some of these 
countr ies. like the U E, are tourist and commerc ial hubs with very h igh incom ing 
and outgoing traffic . Characteristical ly, most of the Gu lf  countries have a highly 
ad anced healthcare system with h ighly sophisticated technical interventions 
being rout inely exerc ised. Th is, of course, means that the number of patients with 
compromised defense systems is h igh and it also means the extens ive use of h igh-
power antibiotics. Regretfu l ly, however, this advanced level of curative med icine 
i s  often not matched w ith equal ly wel l-organized and wel l-maintained ant ib iotic 
regu lation. 
I n  the last two decades E. coli, fol lowed by K. pneumoniae, P. aeruginosa 
and M R SA have been the most common microorganisms in the Gu l f  with 
emerging resistance (A ly and Balkhy 20 1 2) .  
In Saudi  Arabia, resistance to extended-spectrum cephalosporins due to 
ESBL production varies from 6% up to 3 8 .5%. I n  addition, considerable levels  of 
resistance are now encountered in  the community. A study has revealed that 
-- - ------------------------------------------------------------------------------------ -------- ----
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1 2 .3% of health individuals  were asy mptomatic feca l  carriers of E BL-
produc ing E. coli and K. pneumoniae (Zo\ awi et  a ! .  20 1 3) .  Regard ing E B Ls 
genotypes, blaSI-fV - l i ke, a wel l as blaCTX-M - l ike, and blaTEM were common among 
E B Ls i olated from I-Dhahran c ity in 2006 and in two hospita ls  in  Riyadh in 
2007, \\ ith blasllv dom i nating among K. pnellmoniae. Regarding non-fermenting 
pathogen, in P. aerugino a the bIaGE ,  blaVEB and blaOXA genes, whi le ill 
Acinetobacter blapFR and blaGES were encountered (Zowawi et a ! .  20 1 3) .  
The emergence of  carbapenem-resistant Enterobacteriaceae in  Saudi  
rabia has been not iced since 2000. I n  a study done between 2002 and 2003 in  
the Ea tern prov ince of  Saudi Arabia, 1 4% of ESBL-producing E. coli and K. 
pneullloniae i so late showed increased M ICs to imipenem and meropenem 
(Zowawi et a ! .  20 1 3) .  An outbreak of carbapenem-resistant K. pneumoniae in 
Saudi Arabia was reported from R iyadh from December 2009 to August 2010 
where a l l  i olates had a l tered outer membrane OM P3 6K and carried the 
carbapenemase gene blaoXA-48 (Zowawi et a ! .  20 1 3) .  The rate of carbapenem-
suscept ib le P. aeruginosa iso lated from the ICU of a tertiary hospita l in  R iyadh 
\J as 66% in 2004 but dec l ined to 26% by 2009 (AI lohan i  et a l .  20 1 0) .  Metal lo-�-
l actamases (MBL)  have emerged as a common mechan ism of carbapenem 
resi stance in P. aeruginosa in Saud i Arabia with V I M  being the most prevalent 
M B L  type. P. aeruginosa isolates harboring blarMP and blaOXA-lO have been a lso 
identified (Zowawi et a ! .  20 1 3) .  OXA-23 and OXA-40 were found in  
A cinetobacter (Zowawi et  a l .  2013) .  
--------- ----------- - - - - --------- - - - - ------ - - - ----------------- - ----------- - - ---------------- ------
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In KU\\ a it, the prevalence of E B Ls has been also on the rise. A tudy on 
urine i olates between 2005 to 2007 howed that 26% and 1 2% of K. pneumoniae 
from hospital, and community-acquired urinary tract i nfect ions were E B L  
producers. The re pecti  e figures for E. coli were 28% and 17% (AI  Benwan et a ! .  
2 0 1 0). Another tudy i n  2006 reported even higher figures, i .e. 62% for E coli 
and 82% for K. pneumoniae (Jamal et a! .  2009). blacTx-M genes have been the 
mo t common ly found ones in E. coli \ ith CTX-M- 1 5  being the dom inant type. 
Other E B L  gene uch as blaTEM- l ik gene have been detected in Salmonella sp. 
i o late , bla HV- 1 12 in  K. pneumoniae and blaVEB i n  P. aeruginosa i so lates 
(Zowawi et a ! .  20 1 3 ) .  Carbapenemase-produc ing strains of E coli and K. 
pneulIIoniae have a l so been encountered in Kuwait (Zowawi et a ! .  20 1 3).  
A cinetobacter res istance to carbapenems is  now a major problem i n  the country 
with 64 .3% resistance to imipenem and 66. 1 % res istance to meropenem. Severa l 
of  the stra ins  express OXA-58 type carbapenemase (Afzal-Shah et a l .  200 1 ,  
Coelho et a l .  2006, Jama l  et a l .  2009). 
I n  Omani hospita l s  ESBL produc ing E coli and Klebsiella isolates are a lso 
common. A study between 2004 and 2005 showed that 60% of E S B L  producers 
were E coli and 40% were K. pneumoniae, although it was not revea led of what 
proport ions these spec ies were ESBL producers (Rafay et a l .  2007).  The most 
commonly identified genes were blaSHV and blacTx-M (Zowawi et a ! .  20 1 3) .  
Several carbapenemases were a lso detected in the Sultanate of Oman:  NDM- l,  
OXA-4 8  and OXA-18 1 have been encountered in K. pneumoniae and in  Ecoli 
(poire l  et a ! .  20 1 1 b, Potron et a l .  20 1 1 b, Pfeifer et a J .  2012) .  
------------------------------------------------------------------------------------- --------------
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[n Qatar, E B L  production wa demonstrated in  27.8% of E. coli and 1 8% 
of K. pneumoniae i olates during a stud bet� een 2007 and 2008 of 425 of b lood 
cu lture i o late col lected from the same ho pital (Khan et a l .  20 1 0). From this 
count data on carbapenem resistance in Enterobacteriaceae have not been 
avai lab le, but in 2007-2008 it was found to be 4 1 .5% among Acinelobacter and 
1 4 .3% P. aerl/gino a of b lood c u lture isolates, respectively ( Khan et a t .  20 1 0).  
In the Kingdom of  Bahrain, a recent study showed that 22 .6% of 1 1 , 886 
Enterobacteriaceae i so lated from 2005 to 2006 were ESBL producers, mostly 
from inpatient spec imens w ith E. coli being the major ESBL producer (52 .5%) 
fol lowed by K. pneumoniae (24.3%) and Proteus spp. ( 1 7 .6%) (B indayna et a J .  
2009) . Carbapenemases (OXA-23, OXA-58 and OXA-72) were identified in 
Acinetobacter isolates (Zowawi et a J .  20 1 3) .  
The pre ence of ESBL prod ucing organisms is  wel l -documented in  the 
UAE, w ith CTX-M- 1 5, SHV, TEM and PER being the most common types 
(Rot imi  et a t .  2008, A I -Zarouni et a l .  20 l 2, Opazo et a l .  20 1 2). Interestingly, 
CTX-M - 1 5  have been a lso identified in isolates of Enteroaggregative E. coli 
(EAEC) with a gene associated w ith I SEcpi on a plasmid,  i .e. the first of its kind 
i n  th is  group of pathogens ( Sonnevend et aJ .  2006).  By now the spread of 
carbapenemase-produc ing stra ins is  a l so described both in  Acinetobacter 
(Ghazawi et a I . ,  20 1 2), as wel l  as i n  Enterobacteriaceae (Sonnevend et a l .  20 1 2; 
Sonnevend et a J .  2013) .  
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nt i l  the time \\ hen this project \\ as in i tiated, only D M  and OXA type 
carbapenemase , but not V I M, I M P  or KPC type enzymes, had been found in the 
Peni nsula .  
1.3. The Carba penem 
Carbapenems are derived from thienamyc in, a natural ly occurring 
antibiotic produced by the soi l  microorganism Streptomyces cattleya (Papp­
Wallace el al. 20/1). De e loped in the 1 980s, imipenem and meropenem, the first 
members of the carbapenem c lass, had a broad spectrum of antim icrobial activ ity 
that i nc l uded coverage of P. aeruginosa, making them important components of 
the armory of drugs used to treat nosocom ial infections. Unt i l  that t ime, a lmost a l l  
Enterobacteriaceae were s u  cept ib le to carbapenems (Papp-Wal lace e t  a l .  20 1 1 ) . 
Among carbapenems, imipenem, pampenem, and dOrlpenem are potent 
against Gram-posit ive bacteria whi le meropenem, ertapenem, and doripenem have 
s l ight ly more activ ity against Gram-negative organisms. However, both imipenem 
and panipenem are deactivated by dehydropeptidase I of the human renal brush. 
Therefore, they are co-admin istered with an enzyme inh ib itor i .e .  c i l astat in 
(papp-Wal lace et al .  20 1 1 ) . 
A s  w ith a l l  �-lactams, carbapenems are structura l ly re lated to penic i l l ins  
" penams·'. The d issim i larity is  that i n  them a carbon ("carba-") replaces the su lfur 
atom at position 1 ,  a double bond exists between C-2 and C-3 ("-penem") and a 
hydroxyethyl side chain is present in p lace of the acylamino group shared by 
---------------------------------------------------------------------------------------------------
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penic i l l i n and c phalo porin . re u l t ing in  re istance to m o  t �- Iactama e 
(FI GUR E 2.) (Brad Ie) 1 997, Mouton et a l .  2000. Papp-Wal lace et a l .  10 I I). 
" " 










FI GURE 2. tructura l  comparison of the �- Iactam ant ib iotics ( Papp-Wa l lace et 
a l .  20 1 1 ) . 
Carbapenem are bacteric ida l  ant ib iotics.  Their mode of act ion is s im i lar  
to that of other p- Iactam ant ib iotics. i .e. they inh i bit  bacteria l  transpeptidases 
imol ved in  pept idoglycan synthe is  of the cel l wa l l  by b ind ing 'v\ith h igh affini t. 
to pen ic i l l in b ind ing prote ins  (PBPs).  Unl i ke other p-Iactam ant i biot ics, and 
s i m i lar to ami nogl) cosides and fluoroqu ino lones. the d isp lay a s ign ificant post-
ant ib iotic effect agai n  t Gram-negati e bacteria l  pathogens (Hashizume et a ! .  
1 98�. Majchercz) k and  L ivermore 1 990, Papp- Wal lace e t  a l .  20 1 1 ). 
Current l) . carbapenems are frequently prescri bed for severe sepsIs. 
part icu lar ly for patients 'v\ ith recent health care-assoc iated exposures ( Mal1in et a ! .  
2 0 1 3 ) .  Thei r  efficacy has  been emphasized by  several studies (End imian i  e t  a l .  
2004. Paterson e t  a l .  2004). The use of carbapenems. measured i n  a sample  from 
35 un ivers i ty hospi ta l s  in  the Un ited States, rose b 59% between 2002 and 2006 
(Pakyz et a1 . 2008). 
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104. Ca rba penem Re j ta nce i n  Enterobacteriaceae 
I n  the 80 and early 90s Enterobacteriaceae started becoming resistant to 
ad anced. 3rd and 4th generat ion cepha losporins by acqu iring e tended-spectrum 
beta- lactama es ( BLs). Consequently, the use of carbapenems i .e. drugs not, or 
only weakly. affected b these enzyme , has been increased (Rahal et a l .  1 998).  
in e the 2000s, the spread of E B L-producing E. coli in the commun ity further 
aggra ated the situation (Pitout and Laupland 2008 Perez and Van Duin 20 1 3 ). 
Therefore, the prevalence of carbapenem resistant Enterobacteriaceae (CRE) 
i a lated from medical samp les continues to rise worldwide (van Duin et a l .  20 1 3 ) . 
A lanningly, by 2009-20 1 0, the National  Healthcare Safety Network from 
the Centers for Di sease Control and Prevention (CDC) had shown that 1 2 . 8% of 
K. pneurnoniae i o lates re lated to b loodstream infections were not suscept ible to 
carbapenems (S ievert et a l .  20 1 3 ) .  I n  20 1 2, 3.9% of short-stay acute-care hospitals 
and 1 7. 8% of long-tenn acute-care hospitals  described the min imum of one CRE 
health care-associated infection. Moreover, the rate of Enterobacteriaceae that are 
CRE have i ncreased fou rfold over the last 1 0  years (Perez and Van Duin 20 1 3 ) .  
Resistance to  antib iot ics other than the �-Iactam c lass is  regu larly present 
in these stra ins  making them rea l ly mu lti-drug res istant (MDR).  Frequently, the 
genes of res istance to am inoglycosides, tetracyc l ine, su lphonam ides are co-
local ized on the same p lasmid as the genes re lated to �-lactam resistance 
(Martinez-Martinez 2008).  I mportantly, d ifferent carbapenems differ in their 
activity on non-fermenting Gram-negative bacteria. Pathogens, such as A. 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - � - - - - - - - - - - - - - - - -
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bal/manni or P. aerugll10 a exhib i t  natura l resistance to  the so cal led Group 1 
carbapenem (exempl i fied by ertapenem), \ h i le Group 2 agents are effective 
aga inst them, un le there are some acqu i red resistance mechanism present ( ousa 
et a l .  20 1 3) .  
The treatment choices for eRE are l im ited to  col ist in  (polymyxins), some 
aminoglycos ide , t igecycl ine, and fosfomyc in,  i .e .  agents considered as "drugs of 
last resort" (Ouderki rk et a1. 2003, Falagas and Kas iakou 2005, End imiani  et a ! .  
2009, Perez and Van Du in  20 1 3) .  Polymyx ins and t igecyc l ine genera l ly have in 
vitro acti i t)' aga inst C RE. The use of these drugs i s  not w ithout controversies, 
however. Polymyx ins  are cons iderably toxic,  and because of its pharmacoki netic 
features, t igecyc l ine is  not ideal to treat blood-stream infections (Perez and Van 
Du in  2013).  Furthermore, its bacteriostat ic nature makes i t  l ess opt imal in patients 
w ith decreased immunologica l  fitness. To aggravate the s ituation even further, 
re i stance to both drugs is a l so emerging (Ouderk i rk et a 1 .  2003, N ix  and Matth ias 
20 1 0, Tarch i n i  20 1 0, Prasad et a 1 .  20 1 2, Perez and Van Duin 20 1 3).  
The use of h igh-dose prolonged-infusion carbapenem therapy is  a poss ib le 
approach i n  a comb i nation regimen i n  CRE infect ions when carbapenem M ICs 
are S4 mg/L (Daikos and M arkogiannaki s  20 1 1 ) . Moreover, certa in  human stud ies 
and ones us ing murine models suggest that double-carbapenem therapy may be 
effective in some i nstances (Bu l ik  and N icolau 2011). Neverthe less, the 
effectiveness of carbapenem therapy, whether in comb ination regimens, in a h igh-
dose prolonged infus ion, or the "double carbapenem therapy" need to be further 
studied (Nico l le  et a l .  2005, Bu l i k  and N icolau 20 1 1 ,  Tumbare l lo et a 1 .  2012) .  
- - - - - - - - - -- - - - - - - - -- - - ---- - - - - - - ------ -- - - - - - - - - - ------ - - - - - - - - - --- - - - - - - -- - --- - - - - - - - - - - - - - - ---- - -
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I n  Enterobacteriaceae, nv o major mechanisms are responsible for 
carbapenem resi tance. One is JO combination with 0 erexpression of p­
lactamase ha ing, on thei r  own, l imited activ ity against carbapenems, and the 
decrease of the intrace l l u lar concentration of the drug. This may take place either 
b l im it ing the ir uptake or, e ldom by increasing thei r  efflux antibiotics. The 
econd, more important, mec han ism is the prod uction of various carbapenemase 
(F IG UR E  3. ) ordmann et a l .  20 1 2) .  
1.4. 1 .  Non-Carba pen e m ase-Med iated Resista nce 
Porins of  Enterobacteriaceae are spec ific prote ins that form hydroph i l ic 
channels, or pore , that perm it a selective uptake of d ifferent types of molecu les 
such as essential  nutrients and other compounds, inc l ud ing antibiotics, through the 
outer membrane (FIG UR E  3.) (Koebnik  et al. 2000, Pages et a l .  2008). Hence, 
these channels can serve as a bott le-neck for compounds passing the outer 
membrane as their actual number impacts the amount of drugs reach ing the 
perip lasm ic space. OmpF and Ompe porin fami l ies are the first porins in 
Enterobacteriaceae that contribute to the uptake of ant ib iotics (Pages et a l .  2008). 
- - -- - - - - - - - -- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -- - -- - - - - - - - - -- - - - - - - - - - - - - - - -- - - - --- --- - - - --- --- - - - - - -
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F I G U R E  3 .  l echanisms of �- Iactam res l tance In Enterobacteriaceae 
( ordmann et a l .  20 1 2 ) .  
A decrea e In  pon n  expres Ion. or an) change in  the act ivit  of outer 
mem brane porin , can affect anti biotic res istance. This decrease in the number 
of pori ns in the outer membrane m ight be observed as a response to 
ant imicrobial products so antim icrobia l  exposure it e l f  may regu late ponn 
synthesis .  (Armand-Lefevre et a l .  2003, N ika ido 2003, Chia et a l .  2009, 
Doum ith et a l .  2009, hin et al .  20 1 2 ). L im itat ion of the drug uptake a lone, 
ho\\ e\ er. is un l ikely to cause c l i n ica l ly relevant carbapenem resistance. On the 
other hand, \o\ h i le enzymes with l im ited carbapenemase act iv i ty may not be 
effic ient enough a lone against h igh drug concentrations, once the uptake is 
l i m ited b) pori n 10 s, the decreased amount reaching the peri plasmic space 
m ight be hydrolyzed suffic ient ly enough. This is particu larly the case if  less 
effecti e enzymes are gett ing overexpressed, to cause a sign ificant. c l i n ical ly-
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re levant decrea e in  su cept ib i l ity ( rmand-Lefevre e t  a l .  2003. Martinez-
Martinez 2008, Doum ith et a l .  2009 hin et a l .  20 1 2) .  
Different enzyme , e.g. mpe enzyme , certa in  E B Ls, some other c lass 
A ( ee later) cepha lo porina e be long to this category. Important ly, res istance 
due to this combined mechanism, whi le it can be extensive, is  usua l ly considered 
less important, part icu larl from an epidem iologica l  point of view compared to 
re i tance caused by carbapenemase production. Porin mutants often a lso lose 
some of the i r  fitness as they became ineffic ient in the uptake of not only 
antib iotics, but a l so of other, physio logical ly-important compounds. 
Furthennore, this res istance tra it i s  unl ikely to spread as it is re lated to mutations 
in  the chromosome, i nstead of loca l ized on mobi le e lements. (Lart igue et a l .  
2007, Pages e t  a l .  2008, Doumith e t  a l .  2009, Garc ia-Fernandez et a l .  20 1 0) .  
An a lternative c ause of deve loping carbapenem resistance without 
produc ing carbapenemases is  the overexpresslOn of efflux pumps such as the 
overexpression of the AcrA efflux pump component in  Enterobacter aerogenes 
that resu l ted in the development of imipenem resistance ( Bornet et a l .  2003).  
everthe less, this mechan ism is considered second in  importance compared to 
porin-enzyme-re lated res istance. 
- - - - --- - - - -- - - - - - - - - - - - - - - - - -- - - - - - - - - - - - -- - - -- - -- - - -- - - - - - -- -- - - - - - - --- - - -- - - - -- -- - - - - - -- - -- - - - - - -
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I A.2.  Carba penema e 
The mo t effective defense of the bacteria l  ce l l  against carbapenems is due 
to the production of spec ia l  groups of  p- lactama e with high affmity to members 
of thi group of p- lactam , i .e .  to carbapenemase . ME- 1 and I M I - l were the 
fir t carbapenemases ident ified in  Enterobacteriaceae in the Un ited Kingdom in 
1 982 and I M I - l in  the U A in  1 984, respectively (Yang et al .  1 990, Rasmussen et 
a l .  1 996). The first erine carbapenemase reported was NmcA, a chromosomal ly-
encoded enzyme, d iscovered in  an E. cloacae c l inical  i solate (Naas and 
ordmann 1 994). ince then. carbapenem-resistant Enterobacteriaceae have been 
reported global ly. main ly as a consequence of the extens ive acquis ition of 
carbapenema e genes (Queenan and Bush 2007) .  Enzymes w ith considerable 
carbapenemase ac itiv ity ( i .e .  higher than those of ESBLs and AmpC enzymes) 
can be found in three of the four Ambler c lasses of p-lactamases (TA B L E  1 .) 
ordmarm et a l .  20 1 2) .  (ESBLs and c lass C AmpC enzymes with min imal  
carbapenemase activity were d i scussed ear l ier). 
Class A Carbapellemases 
Regarding the Ambler c lass A carbapenemases, three mam types are 
known :  the mcAl IMI ,  S M E, and KPC enzymes (Walther-Rasmussen and Hoiby 
2007).  A l l  these enzymes hydrolyze a broad variety of p- lactams inc l ud ing 
penic i l l i ns, cephalosporins, carbapenems, and aztreonam (TA B L E  1 .) .  They have 
a serine-contain ing act ive s ite at position 70 (Ambler numbering of c lass A P­
l actamases). They are inh ibited in vitro by c lavulanic ac id and tazobactam 
- - --- - - - - - ----- - - --- - - - - --- - - - - -- --- - - - - - - --- - - - - - - -- - --- - - - - -- - - - - - - - - ----- - - --- -- - - ---- ---- - - - - --
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(TABLE 1 ) . A fourth type of  Ambler A group enzy mes re lated to  the GE type 
B-Iactama e wa al 0 identified. Origina l ly this group was considered to be a 
' c Ia ica l '  ESBL becau e GE - 1  d id not posse s carbapenemase activ ity . 
Ho\'" ever, lately. it weak but sign ificant carbapenemase activ ity has been 
recognized (Nordmann et a l .  20 1 2) .  
At pre ent ,  K PC enzymes are the c l i n ica l ly mo t sign i ficant enzymes 
among c las A carbapenemases. The first stra in  of K. pneumaniae produc ing K PC 
''v a i olated in 1 996 in the Eastern part of the USA (Y igit et a l .  200 1 ). Up  unt i l  
now, mUl tiple KPC variants have been recognized from K PC-2 to KPC- 1 2  ( 1 1 
ariants). KPC-producing tra ins  spread widely and have been identified in 
d i fferent countries such as the ent ire US territory, Puerto Rico Colwnbia, I ta ly, 
G reece, I srae l .  and Ch ina (Navon-Venezia et a l .  2009, Nordmann et a l .  2009). 
Outbreaks of KPC-produc ing strains have a lso been reported in  many European 
countries and in South America (Navon-Venezia et a1. 2009, Nordmann et a l .  
2009) . 
KPC enzymes have been described main ly from nosocomial K. 
pnellmaniae isolates and to a lesser degree from other enterobacterial  species. 
Fatal ity to infections due to KPC-producing stra ins is high, around 50% or more, 
due to mul t i-drug resistance among KPC-produc ing stra ins that may resu l t  in 
fai lure in first l ine therapy (Borer et a l .  2009, Nordmann et a l .  2009). 
- - - - - - - -- - -- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -- - - - - - - - - - - - - - - - - - - - - - - - - - - - -- - - - - - - - -
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CIa D carbapellema e '  
The c ia  D carbapenemases ca l led OXAs for oxac i l l inases' ,  inc l udes 
over 200 enZ) meso e era l, but not a l l  variants exhibit carbapenemase activity, 
a lthough at ery d i fferent Ie e ls .  Actua l ly, rn a  t have weak carbapenem 
hydrol} zing abi l it} and do not inacti ate expanded-spectrum cephalosporins 
(TA B L E  1 . ) .  The are inh ib ited by NaCI but not by c lavulanic ac id or EDTA 
(TA BLE 1 . )  (Nordmann et aL 20 1 2) .  
Most c lass D carbapenem hydro lyzing enzymes have been found in 
Acinetobacter spp., where blaOXA-5 1 i s  cons idered a spec ies-defin ing gene (Turton 
et a l .  2006). OXA-48 has been discovered in Enterobacteriaceae. The fi rst 
identified strain produc ing OXA-48  was a K. pneumoniae isolate recovered in 
Turkey in 2003 (Po i re l  et aL 2004). Today OXA-48-l ike enzymes represent a 
group i ncreasingly encountered in many countries of the world (poire l  et a l .  
20 1 2) .  osocom ial  outbreaks due to OXA-48-l ike enzyme produc ing strains have 
been described in  Turkey and in several other countries (Carrer et a l .  2008, 
ordmann et a l .  20 l l a) .  A s ingle p lasmid of approximately 62 kb is  the main 
source of the blaoXA-48 gene d issem i nated in  a variety of enterobacterial  spec ies 
(potron et a l .  20 1 1 a, ordmann et aJ. 20 1 2) . 
- - - - - - - --- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -- - - - - - - -- -
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Clas B carbapellemases 
CIa B enZ) me are cal led meta l lo-�- Jactamases (MBL)  as they requ ire 
Zn2 ion(s) in their active site. Con equent ly, they can be inhibited by chelators of 
di a lent cat ion such a ethy lenediaminetetraacetic acid (EDTA) (TA BLE 2.)  
(Zhao and H u  20 1 0). These enzymes ha e a broad spectrum of hydro lytic act ivity, 
they hydro lyze a l l  pen i c i l l ins, cepha losporin , and carbapenems, with the 
exception of monobactams (TABLE 2 . )  and they are not inactivated by 
commerc ia l ly ava i lable �- Iactamase inhibitors (clavulanic acid, tazobactam, or 
su lbactam) (Miriagou et a l .  20 1 0, Comagl ia  et a J .  20 1 1 ) . 
The tirst M BLs identified were chromosomal ly encoded enzymes and the 
bacteria were main ly opportunist ic and soi l- inhab itants (Bacillus cereus, 
Aeromonas spp.,  and Stenotrophomonas maltophilia) (Zhao and Bu 20 1 0). The 
first M B L-re lated nosocomia l  outbreak was reported from Europe (Laurett i et a J .  
1 999; Comagl ia  e t  a ! .  20 1 1 ) . S ince the 1 990s a remarkable number of 
transferable M B L  genes has been described in  Enterobacteriaceae and 
P eudomonas spp. . The most common types of acqu i red MBLs In 
Enterobacteriaceae are members of the I M P  and V I M  groups and the various 
a l le les of the recently described NDM group (Wa lsh et a l .  2005). The V I M  and 
I M P  M BLs have dissem inated mostly in  Pseudomonas aeruginosa and, at least in 
some regions, in  A cinetobacter baumannii and Enterobacteriaceae, particu larly 
K pneumoniae. Moreover, they have been identitied in  d ifferent spec ies as 
Salmonella enterica, E. coli, Enterobacter spp. , and Pseudomonas spp. (Miri agou 
et a1. 20 1 0) .  
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Other acq u i red M B L  inc l ude PM- I ,  G I M- l ,  I M- l ,  D IM- I ,  A I M- I ,  
K H  I - \ ;  (Gupta 2008, ekiguchi et a ! .  2008). I t  was the emergence and fast 
global pread of the OM type enzymes which prope l led M BLs into the center of 
attention. OM- I -produc ing bacteria were in i tia l ly found mainly in the U K  
I nd ia, and Paki tan, but by no, i t  has spread globa l ly not sparing any o f  the 
continent (Kumara amy et a l .  20 1 0, ordmann et a l .  20 1 1  b) .  
Re istance caused by acquired M B Ls among major Gram-negative 
pathogens such as Enterobacteriaceae, has serious c l in ica l  and epidemiological 
impl ication and i a matter of considerable concern a l l  over the world (Cornagl ia 
et a ! .  2007). Fata l ity assoc iated w ith M B L  production varies from 1 8% to 67% 
(Daikos et a1 . 2009) .  The lack of c l i n ica l ly  available inhib itors e l im inates even the 
theoretical  possibi l ity to interfere w ith its action in vivo. Furthermore, their 
frequently plasmid-coded nature a l lows an efficient inter-strain  and inter-spec ies 
tran fer further emphasizing the c l in ica l  and epidemiological importance of M B Ls 
(Walsh et a l .  2005).  
1.5. M eta l lo-�-Lactamases 
I n  1 989 , i th in  the Bush-Jacoby-Medeiros functional c lassification, based 
on their sequences, M B Ls were grouped into three subclasses, B l , B2 and B3 
( Fast and Sutton 20 1 3) .  Members of the three subc lasses vary i n  the structure of 
their active s ites. The act ive site in  enzymes of subc lasses B l and B3 has two 
zinc ions, whi le in enzymes of subc lass B2 there is only one zinc ion and these are 
c haracterized by narrower substrate specificities (Garau et a1 .  2004). Every 
-- - - - -- ------- - -- - - ----- - - -- - - ------ - - - - --- - - - - --- - -- --- - - - - - -- --- ---- - - - ---- - - - ------- - - - ------ - --
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ubc las has se era l  d i fferent type o f  M BLs, and se era l types h a  e mu lt iple 
a l le l ic ariant . In order for a M B L  enzyme to be c ia  sified as a ne\ subc lass, 
minimum 30% of amino acid d ivers ity is required (Comagl ia et a l .  2007). 
ubc l ass B 1 enzymes hare more than 23% ident ity, \ h i le  subc l ass B2 
enzymes pre ent on l 1 1  % of identity with subc lass B 1 members. Subclass B3 
M B L  ha e onl  n i ne conserved residues when compared with the other M BLs 
(Bebrone 2007). I I  of the acqu ired types of MBLs belong to subc lass B 1 .  They 
are the one mo t often captured, and further spread by mobi le  genetic elements, 
a fact explaining thei r  wide-spread nature compared to the other two subc lasses 
(Bebrone 2007). 
1.5. 1 .  I n h i bi tors of Metal lo-p-Lacta mases 
One of the most effective antibacterial strategies 1 0  the treatment of 
bacterial infections is  the combination of p- Iactams and p- lactamase i nh ib itors. 
The success of these agents is c learly highl ighted by the effic iency of amoxic i l l in 
and c lavulanate ( M i l ler et a 1 .  200 1 ). 
M BLs are d ifferent from the senne �lactamases as they have a wide 
active-site groove making them able to accommodate most P - lactam substrates 
and hence to have a broad spectrum of activity. They are resistant to the 
i nactivation effects of serine inhibitors, such as c lavulanic ac id and sulbactam, as 
these compounds are poor substrates. C lavu lan ic ac id interacts d irectly with c lass 
- 2 3  -
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enzyme and fonn a stable co  a lent intennediate, whi le MBLs  do  not form 
such intennediate (Wal  h et a 1 .  2005). 
Aztreonam i not hydrolyzed by any of the M B Ls, so it has been 
inve tigated whether it might be used as a therapeutic M E L  inhibitor. When 
combined \ ith h igh doses of aztreonam, a significant decrease in lung bacteria l 
count wa observed \ hen imipenem was given at the h ighest doses 
recommended for humans.  everthe less, the treatment was unable to erad icate 
pneumonia in animals  caused by P. aeruginosa producing V I M-2 enzyme (Bel la is  
et a I .  2002) .  
To further comp l icate the matter subc lasses of MBLs exh ibit considerable 
variations in their active s i te structure, so a s ingle inhibitor effective against a l l  
M B L  is  highly un l ike ly t o  be found (Da iyasu et a l .  200 1 ). Furthennore, good 
affinity of the inh ibitor to the enzyme per se does not guarantee a considerably 
lower M ICs against �- Iactams, as was shown experimenta l ly i n  P. aeruginosa 
conta in ing M B L  genes (Daiyasu et a 1 .  200 1 ,  Sch i l l ing et a ! .  2003) .  
To find c l in ica l ly useful,  spec ific inhibitors for MBLs is particu larly 
d ifficul t  s ince such inh ib itors must not have act iv ity towards human meta l lo-
enzymes (e.g. angiotensin converting enzyme). Severa l inhibitors were studied, 
such as th ioesters derivat ives, trifi uoromethyl alcohols  and ketones, su l fonyl 
hydrazones tricyc l ic natural products, succ inic ac id derivat ives, biphenyl 
tetrazoles, cysteinyl  peptides, carbapenem and penic i l l in derivatives, degradation 
products of cephalosporins, s imple thiol  compounds such as mercaptoacetic ac id 
and thioesters, th iomande l ic acid, captopri l ,  derivatives of benzohydroxamic acid 
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a n d  other . Regretfu l ly, the} had moderate a tiv ity against one o r  two meta l lo-�-
l actama es. on ly (Bebrone 2007, Fast and utton 20 1 3). 
Con equentl , effective inh ibition of M B Ls can be achieved on ly by 
che lation, i .e .  remo a l  of the d ivalent cations requ ired for the function of the 
enzyme. Inhibitors effective in vitro are metal chelators EDTA, 0- 1 ,  1 0-
pbenanthrol ine and dipico l in ic ac id. Understandably however, using them 
c l i n ica l ly, in vivo. is not a feasible option (Bebrone 2007). 
1 .5.2. Genet ic  O rga n izat ion of M B L Genes 
Genes of M BLs can e ither be located on the chromosome (often referred 
to as res ident M BLs) or can be mapped on mob i le elements. As  these latter ones 
are often transferred horizonta l ly, these enzymes represent the majority of 
acqu i red M B L  (Bebrone 2007). Resident M BLs are found in  on ly a few spec ies 
of c l i n ica l  sign ificance, e .g.  S. maltophilia, Bacillus spp., B. fragilis and P. otitidis 
(Yano et a l .  200 1 ) . Regard ing acq uired MBLs, severa l types have been detected 
and described. I MP-type, V I M -type, SPM-type and NDM-type enzymes have 
been detected in mult ip le  stra ins  of Enterobacteriaceae, P. aeruginosa, A. 
baumannii, and other Gram-negative non-fermenters (Bebrone 2007). 
The vast majority of acqu ired M B Ls belong to the subc lass B 1 whi le 
enzymes belonging to sucbc lass B2 are coded on less mobi le genes located on the 
chromosome. Concern i ng B3 enzymes, they are genera l ly on large p lasmids, as 
wel l  as on the chromosome (A vison et a l .  200 1 ,  Bebrone 2007). 
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Genes cod ing for transferable MBLs  are genera l ly carried on  gene 
ca sette of type I or type 3 integrons. Integron are assembl platfomls that 
capture exogenou open read ing frames (ORFs) by s ite-specific recombination 
a l lo'V\ ing the ir e. pre ion, thus transforming them into functional genes. A l l  
integron are made up of three regions of importance for the incorporat ion of 
exogenous genes: a gene (intI) encod ing an integrase of the tyrosine-recombinase 
fami ly ;  a primary r combi nation s ite (aUI); and a promoter (Pc) directed outwards 
to rea l ize the tran cription of the captured genes (Ha l l  and Col l i s  1 995).  I ntegron-
encoded integra es can capture d ifferent un its of c i rcu larized DNA or gene 
ca ettes. I ntegration takes place at the allI site, downstream of the res ident 
promoter, � h ich perm it the express ion of the genes in the cassette. Gene 
cas ettes that are integron- inserted conta in a s ingle gene and an imperfect inverted 
repeat at the 3 '  end of the gene cal led an allC site (or 59-base element). The allC 
s ites are a varied fam i ly of nucleotide sequences that are important for the 
recognition by the integrase. 
Related to the variety of genes encod ing i ntegrase, eight c lasses for 
i ntegrons have been recognised and characterized (Zhao and Hu 20 1 1 ) . The 
d i ssemination of M B L s  among Gram-negat ive bac i l l i  is med iated by c lass 1 
i ntegrons. A typical  c lass 1 integron contains a 5 '  conserved segment (5 ' -CS), a 
variable region and a 3 '  conserved segment (3 ' -CS) (Zhao and Hu 20 1 1 ) .  C lass 1 
integron has two promoters P I  and P2.  Regard ing the 3 '  -CS, it often consists of a 
partly de leted qac gene (qacEDl)  fused to a sull gene, and is responsible of 
resistance to antisept ics and su lfonamide. The antibiotic res istance gene cassettes 
- - - --- - - - - - - - - -- - -- - - - - - - - - - - - - - - - - - - - - -- - -- - - - - -- - - - - - - --- - - - -- - - - - - - - - - - - - - - - - - - - - - -- -- - - - - - --- - -
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are normal l }  introduced betv. een the 5 ' - and 3 '  -C ( FI G U R E .t.) ( F l u  it and 
chm itL 1 999. Zhao and Hu 20 1 1 ) . 
S CS fie 
R2 gene cassette 
F I G U R E  4 .  The c l ass I integron and the process to capture gene cassette (Zhao 
and Hu 20 1 1 ) . 
Gene ca ettes are c i rcu lar 0 A molecu les of around I kb. They are 
i nserted b) a spec ific site of recombi nation between the 5 '  - and 3 '  - conserved 
egments of an integron.  The number of gene cassettes can vary between 0 for I nO 
to at least five ( F l u it  and Schmitz \ 999).  evera l  copies of gene cassettes can be 
presented in the same integrin.  for example  the two copies of oxa2 that exist in 
[ n  1 ( tokes and Ha l l  1 992. F l u it and Schmitz 1 999).  
Most integrons conta in ing gene cassettes for M B Ls a lso carry other gene 
cassettes encod ing for other antibiotic c lasses. d is infectants, or other �- Iactamase 
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gene . o. integron tran fer might result  in a single- tep transfer of a complex 
mu lt idrug-re i tant phenoty pe (F lu i t  and chmitz 1 999, Cornagl ia  et aJ. 20 1 1 ) . 
The majority of genes encod ing for I M P- and V I M- type M BLs are found 
In c lass 1 integron ( ee later in deta i l s  for V IM-type enzymes), while certa in 
I M P- type enZ)mes m ight be found in c las 3 integrons (Walsh et al .  2005 ). M BL 
genes ma a l so be carried b I CR ( insertion sequence common regions) as in the 
ca e of bla PM- I ,  where the gene is not part of a gene cassette, ne ither found on a 
c ia integron, but beside the I CR variant ISC R4 (Toleman et a l .  2002, 
Toleman et a l .  2006). 
1.5.3. Detect ion  of MBLs 
Currently. no standard ized phenotypic methods exist to detect MBLs.  The 
actual  M IC to carbapenems exhibits great variations accord ing to the enzymes 
expressed and to the genus and spec ies. With some Enterobacteriaceae and some 
A cinetobacter spp. isolates, MIC values, particu larly with imipenem, can be as 
10\ as 1 and 2 mgIL (Yan et a l .  200 1 a, Scoul ica et a l .  2004). Pseudomonas 
carry ing :M BLs strains usua l ly exhibit  h igher carbapenem MICs than 
Enterobacteriaceae. 
Methods to detect carbapenemases, e .g. the mod ified Hodge test (MHT), 
often fai l  to g ive positive reaction with some of the M B Ls, particu larly NDM type 
enzymes, as the presence of d ivalent cations may not be enough to support their 
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action.  upplementing the media w ith them increase the ensit i  i t) o f  this t e  t 
( F I G u R E 5 . )  ( G ir l ich et a l .  20 1 2 ) .  
f\ . 8 
FI G U RE 5. Mod ified Hodge Test (A) and the effect of extra z inc sulphate added 
(8 ) 
Grganisms tested: 1 ,  E. coli JM1 09; 2, K. pneumoniae CGG (CTX-M- 1 5  + porin 
foss), 3. K. pneumoniae BIC (OXA -.J8J; .J, K. pneumoniae PGZ (KPC-2J ; 5, E. 
colT GE,\T (:\TDAf- l) : 6, E. coli RIC (NDM- l) : 7, E. coli A L L  (NDAf- l) Zinc 
lI((afe impro1'ed the A fHTfor E. coli RIC and not for E. coli ALL.  (Girlich et af. 
2012) .  
pec ific detection of  M B Ls i s  usua l ly based on the fact that chelators can 
block the i r  action and is done by the use of a variety of inhib i tor plus p-Iactam 
combinations (TABLE 2. - see page 32) ( Yan et a ! .  2004) .  The degree of  
i nh ibit ion of  M B Ls d i ffers ith d i fferent compounds and the M B Ls enzymes 
have d i fferent resistance to d i fferent substrates .  Ceftazid ime and 1 I11 1 penem are 
t\\ O substrates common ly used in screening M B Ls .  
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For m o  t microbiology l aboratorie . the E-test BL trip i preferred as a 
screening J tern . The trip i part l} permeated ", ith an imipenem grad ient acro 
sev eral d i l ution and the other half "" ith another imipenem grad ient oaked "" ith a 
con tant concentration of DT ( F I G U RE 6. )  ( Walsh et a l .  2002). This te t may 
not be able t detect a l l  M B L-po it ive Enterobacteriaceae due to the 10\\ Ie el of 
"resi tance"' . The d i  k approximation te t may work better. particu larly if  mu lti ple 
ub trate ( i m i penem, ceftaz idime. and meropenem) are used in combination \\- ith 
mu lt ip le inhibitors ( E DT and mercaptopropionic ac id)  (Arakawa et al .  2000, 
ong et al . 2002 ). 
F I G U R E  6. E-te t M B L  strip of an A cinetabacter sp. expressing a V I M-2 M B L  
( Wal  h e t  a l .  2005 ) 
I n  research laboratories. bacteria l  cel l extracts are inspected for the ir 
carbapenem hydro lyzing ab i l ity and whether this hydro lysis  is EDTA sensit i  e .  
This  method i considered the  non-molecu lar " gold standard" . Resu lts show the 
production of the enzyme i rrespective of the strains '  genotype. However the 
problem of us ing EDTA in combination \ ith imipenem is  that a number of M B L­
negat iv e P. aerugino a showed reduced imipenem M ICs in the presence of 
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EDT . That might be  cau  ed  b) the effect of  zinc on  OprD (outer membrane 
porin that a l lows the entry of carbapenem) and the newly described Czc R-Czc 
y tern (Conejo et a l .  2003 , Perron et a l .  2004). 
In case of po itive screen ing resu lts, verification is  often achieved by 
molecu lar techniques in reference laboratorie . The techn iques used to detect 
M B Ls are PCR or D A hybrid ization.  
Taken together MB L s  represent a major, emerging problem, as  (Bebrone 2007; 
omagl ia  et a!. 20 1 l '  Rossol in i  et a!. 200 1 ;  aavedra et a J .  2003 ) :  
they are effic ient carbapenemases with broad spectrum activ ity 
they have a potentia l  to be transferred horizonta l ly 
• their genes often co- locate and c luster with other resistance genes 
we do not have c l i n ica l ly usefu l  inhibitors 
their genes are present in severa l environmental spec Ies serv ing as 
reservoirs 
M thes is  \vi l l  focus on a spec ia l  group of M BLs, the so ca l led V I M -type 
enzymes. 
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1 .6. V1M-T p e  M B L 
Th V I M-type enzyme form one of the most common groups of acquired 
M B Ls. In some region , l ike in I ta ly, the ir frequency actua l ly e ceed that of I MP 
type 1 B L  b a ratio of 4: I ( Rosso l in i  et a l .  2008). 
I .6. 1 .  The Variety of V IM E nzy mes 
The V I M- l  ( Verona integron-re lated meta l lo 13- lactamase- l )  was 
di co ered in erona, I ta l  in 1 997 in  a P. aeruginosa strain .  blavrM_ l ,  the gene 
encod ing for the V I M  - 1 ,  wa integrated into a c lass 1 integron located on the 
bacteria l  chromosome ( Lauretti et a l .  1 999, Zhao and H u  20 1 1 ) . The isolate was 
res istant to a et of �- lactams, inc l uding piperac i l l i n ,  ceftazid ime, im ipenem, and 
aztreonam. The M I C  of imipenem was > 1 28mgIL. B iochemical analysis of this 
strain indicated a carbapenemase activ ity that was inhibited by EDTA and 
restored after addit ion of Zn2+. The c loning of the encod ing gene revea led its 
re lation to B Cl l  from B. cereus, sharing only 39% am ino acid identity. The 
hydrolyt ic pattern of the c loned blavIM- 1  was typ ical  of c lass B enzymes, i .e. 
hydrolyzing most �- lactams except aztreonam; obviously, res istance of the P. 
aeruginosa stra in  to monobactams was not due to M BL-re lated mechanisms 
(Laurett i  et a t .  1 999). The c lass I integron, bearing the blavrM-1 gene, carried an 
i ntegrase gene typical  of c lass 1 integrons, as wel l  as  an aacA -I gene cassette 
encod ing resistance to aminoglycosides (Walsh et a l .  2005) .  
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fter the in it ial  detection of V I M -type enzymes in  P. aeruginosa and 
other Gram-negati e non-ferment ing stra ins, these enzymes al  0 appeared in 
Enterobacteriaceae (Zhao and Hu 20 I I ) . As of today, more than twenty V I M  
a l lotypes were identified ( V I M- 1 -27) .  V I M  variants ha e a characteristic 
geographical d i  tribution \ ith V I M- I and V I M -4 found in  Europe, V IM-3 in 
Taiwan, V I M -6 in Asia and V T M-7 in the USA, while V IM -2 is  distributed 
worldwide (Zhao and Hu 20 J L ) . The V IM-type MBLs  have broader substrate 
pec ificit ie than the I M P-type , and are capable of hydro lyzing 6-a-methoxy­
penic i l l i n  . 
Add itional l  , the V I M -type enzymes have a substant ia l ly h igh affinity for 
carbapenems which is d i stinctive i n  the metal lo-B-Iactamases. I n  this respect a 
con iderab le funct ional heterogeneity was found among d ifferent V I M  al lotypes. 
evertheless 110 c l in ical consequence or significance was associated with these 
d i fferences ( Docqu ier et a I .  2003, Comagl ia  et a I .  20 1 1 ) . 
I n  most cases the mature V I M  enzymes consist of 266 ammo ac id 
residues, whi le  VIM -7 has an amino ac id de letion in  posi t ion 7 w ith 265 am ino 
acids and V I M- 1 8  has 262 residues with a deletion of four amino acids from 
position 1 45 compared w ith other V I M  variants. The amino acid s imi larities of 
the most common V I M  variants range from 72.9 to 99.6% (Zhao and Hu 20 1 1 )  
(TABLE 3. - see page 3 7). 
Below, we provide a brief account on the most important a l le les of these 
enzymes. 
--- - - - - - --- - - ----- - - - - - - - - ---- -- - - - - - -- --- - - - - - - - - - - - - - - --- - - -- - - ----- - - - - ------ - --------- --- - - ----
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blaVTM-2 \ . .  a s  i olated from a strain o f  P. aerugino a that showed resistance 
to most �- Iactam (ceftazid ime, cefepime, and irn ipenem) but not to aztreonam . 
The tra in  wa reco ered from the blood culture of a neutropenic patient in 1 996 
in outhem France (Poire l  et a l .  2000). blaVTM-2 was found to be on a non­
conjugative p ia  mid of ca .  45 kb and located within a gene cassette carried by a 
c i a  1 integron. �- lac tama es V I M - I  and  V I M -2 have 90% am ino acid identity 
(TA B L E  3.) (Poire l  et a I .  2000, Docquier et a l .  2003) .  
equence heterogeneity is mostly observed in the NH2- and carboxy­
terminal  region of V I M - I and V I M-2 .  Late ly, other P. aeruginosa stra ins  that 
carry the same blaVTM-2 gene cassette w ith the same resistance profi le have been 
identified in  France. However the blavlM-2 gene cassettes were integrated in 
d i fferent c lass I integrons, I n 5 8  and In59 .  Th is integron usua l ly carries 
aminoglycoside resistance genes, as wel l  as su lfonamide resistance gene in  the 3 '  
conserved e lement (Po i re I e t  a l .  200 1 ). 
Recently V I M -2-producing P. aeruginosa strains have been a lso 
identified i n  I ta ly and G reece, and eventua l ly have a lso been reported from other 
countries, such as Japan, outh Korea, Portugal, Spain Poland, Croati a, Chi le, 
Venezuela. Argentina, Belgium, and most recently in  the United States (Zhao and 
Hu 20 1 1 ) .  Moreover, V IM-2 has been detected in  other spec ies such as C. 
frelmdii in Taiwan, in S. marcescens i n  South Korea, and E. cloacae in South 
Korea (Wa lsh et al. 2005).  
--- - - --- - --- - -- -- ---- --- - - ----- - - ------------- - --- ------ - --- ---- --- -- ----------- - - - ---- -- --- - -- ----
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V I M-3, "v a found in  P. aeruginosa isolates in  Taiwan. I t  d iffers from 
V I M-2 b two am ino ac id changes and is located on the chromosome (Yan et a l .  
200 I b). 
V I M-4 wa fir t d i scovered in  a P. aeruginosa in  a patient with post-
urgical  cerebrosp inal  infection in Greece (Poumaras et a t .  2002). The stra in  was 
h ighly res istant to carbapenems. The b1aVIM-4 was carried by a c lass 1 integron. 
Compared to V I M - l V I M-4 has only one different nuc leotide result ing in a Ser­
to-Arg mod ification at amino acid posit ion 1 75 (Ser l 75Arg) (poumaras et a l .  
2002, Libi  ch et  a t .  2004). ubsequently,  a V I M-4-producing P. aeruginosa was 
iso lated in weden (G iske et al . 2003) and the same enzyme was a lso identified in 
other spec ies such as i n  K. pneZimoniae and E. cloacae strains in  Italy ( Luzzaro et 
a t .  2004). I nterest ingly, v h i le that blavfM-4 gene in K. pneumonia and E. cloacae 
was located on the same plasmid, the M ICs of imipenem and meropenem for 
these isolates were d ifferent (2 and 0 .5  mgIL for K. pneumoniae and 0.25 and 
0 . 1 2  mglL for E. cloacae, respect ively) ( Luzzaro et al. 2004). 
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VIM-5 differ in fi e amino acids from VIM- l (TA BLE 3. ) .  This allele was 
encountered in Turkey in K. pneumoniae and in P. aeruginosa isolate howing 
re i tance not only to all �-lactams but also to aztreonam (Bahar et al. 2004) .  The 
VI M-6 enzyme was al 0 detected in a P. pulida isolate in Singapore. It differs from 
VI  -2 by a glutamine/arginine change at position 59 and by an asparagine/serine at 
po ition 1 65 and by one amino acid from VIM-3 . Besides exhibiting MICs of >32 
mg/L for imipenem and >256 mg/L for ceftazidime, the strain was also resistant to 
aztreonam ( 1 28 mg/L) ( Koh et al .  2004). 
V IM-7 has been isolated from a P. aeruginosa strain in  Houston, Texas that 
was resistant to all  �- lactams, including aztreonam, and to all  other available 
antibiotics except polymyxin B. It forms a third subgroup among the VIM-type � -
lactamases. The blaVIM-7 gene was located on an approxin1ately 24-kb plasmid and is 
l ikely to be integron-bome (Toleman et al . 2004). 
Based on the phylogenetic tree (Zhao and Hu 20 1 1 )  and considering the 
number of different amino acid residues, VIMs may be d ivided into three subgroups 
(F IGURE 7.): 
• Subgroup 1 involves V I M- I ,  -4, -5, - 1 2, - 1 3, - 1 9, -25 and -26; they have 
9 1 .4-99.6% identity and 1 -23 different amino acid residues. 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
- - - - - - - - - - - - - - - - - - - -
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• ubgroup 2 In o lves 1 5  member that are [ M -2. -3. -6. -8- 1 L - 1 4- 1 8. -20.-
23 and -24. \\ h ich  hare 97.4-99.6% identity and have 1 -7 d i fferent am ino 
ac id res idue . 
• ubgroup 3 ha on l)  ne member. I M -7. \\ h ich presents 72 .9-77% 
i m i larity and 6 1 -72 d i ff! rent amino ac id res id ues after comparison \\ ith the 
other V I M ariant . 
There are no ) temati data c u rrent l y  a a i lable on the rel at ionsh ip  bet\\ een 
the 1 amino acid equence and their  substrate spec i fic it ies or affin it ies (Zhao and 
Hu 20 1 1 ). 
VIM· 1 7  
VIM· 1 0  
VIM·23 
VIM·24 
VIM· 1 5  
V I  ·20 
VI - 1 1 




VIM- 1 4  
VIM-8 
VIM·9 
VIM· 1 6  
Subgroup 2 




VIM- 1 9  
VIM· 1 3  
0 1  
F I G U RE 7. Ph) logenet ic tree of the V I M  fam i ly based on the am ino ac id sequences 
(Zhao and Hu 20 I I ) 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
- - - - - - - - - - - - - - - - -
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1 .6 .2 .  I n tegron Carry ing  blav I \1 
Most of the blaVI':I-1 genes contained by c lass 1 integrons that are generally 
in erted into transposon localized on plasmids or in the c hromosomes. However 
there are e ception , e .g .  the P. putida-deri ed transposon, which carries blaYIM-2 
(tnpA-fnpR-I Ppul  -aaeA 4-blaYlM-2-aadA l -blaoXA_9-tnpR-blaTEM_ I-ISPpu18) but 
thi lack the integron tructure (Zhao and Hu 20 1 1 ). 
In  the majority of cases, blaYlMs are found on the integron with one or more 
anlinoglycoside resistance genes, such as aaeA-I, aaeA 7, aadA 1, aadA2, aadB and 
aaee 1 .  Of these aminoglycosides resistance genes, aaeA -I is the most common, being 
present in some 50% of the 1 1 0 integron structures:  it codes for acetyl transferase 
AAC(6 ' )- Ib  C, I .e .  an arninoglycoside-modifying enzyme gene ( Ramirez and 
Tolmasky 20 1 0). 
E amples of �-lactamase genes co-existing frequently with blavlM includes 
the blaoXA-2, conferring resistance to amino- and ureido-penici l l in and important 
hydrolytic activity against c loxaci l l in, oxac i l l in and methici l l in (Naas and Nordmann 
1 999). Obviously, the expression of al l  co-existing genes that are harbored usual ly by 
the same integron, inc luding the resistance determinants to antiseptics and 
sulfonamide in the 3 '  -CS (qaeED1/sull ), results in the emergence of multi-drug 
resistant bacteria. 
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1 .6.3. The pread of VI M  
To date, VIMs ha e been identified in at least 23 spec ies of Gram-negative 
baci l l i  in more than 40 countries (Zhao and Hu 20 1 1 ) .  Regarding V IM-4, it is found 
mainly in Europe and spread fast in Enterobacteriacae, P. aeruginosa and other 
non-fermenters (Cornaglia et al .  20 1 1 ) .  VIM-4 was reported from: P. aeruginosa 
i olates from Greece, weden, Poland, Austral ia, Hungary and Norway; K. 
pneumonia from Italy and Hungary; Kleb iella oxytoca from Hungary; Enterobacter 
cloacae from Greece and I taly; Acinelobacter spp. from Greece; Pseudomonas 
puNda from Belgium and Aeromona hydrophila from Hungary (Pournaras et al .  
2002, Giske et al .  2003, Libisch et al .  2004, Patzer et al . 2004, Walsh et al .  2005, 
Peleg et al. 2006 I konomidis et al. 2007, Figueiredo et al. 2008, Kristof et al. 20 1 0, 
Zhao and Hu 20 1 1 ). 
I n  the region of orth Africa, V I M-4 produc ing K. pneumoniae have been 
discovered in Tunisia in strains also carrying CTX-M- l S  ESBL, and CMY-4 AmpC 
enzyme.  The bla IM-4 gene was a part of a c lass 1 integron (Ktari et a l .  2006). 
Moreover, a study done at the University of Edinburgh has identified two isolates of 
E. cloacae (E 1 720 and E4293)  from Egypt that carry the blavTM-4 and blaCTX-M- 1 4 
genes on a same plasmid where blavfM-4 was found as a gene cassette in a c lass I 
integron (Dimude and Amyes 20 l 3 ). 
- 4 1 -
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While NDM and OX A8-l ike carbapenemases are increasingly common in 
the rabian peninsula ( hibl et al .  20 1 3, Sonne end et al .  20 1 3 , Zowawi et al .  20 1 3 ) 
at the time of initiating our re earch no VIM-producing Enterobacteriaceae have 
b en reported with the exception of a conference abstract without any fol low up data 
( Da hti et a l .  20 1 1 ) . Therefore we initiated an active search for V IM -type enzymes 
among carbapenem resi tant local isolates. The current thesis summarizes the results 
of the e efforts. 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
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I I .  A I M S A N D  O BJ ECTI VES 
I L L  G eneral A im 
The general aim of  th tudy v as to provide detailed insight into the molecular 
epidemiolog of VI M-producing Enterobacteriaceae in the Arabian Peninsula. 
1 1 .2.  peeiflc Object ive 
• To establ ish whether VIM-producing Enterobacteriaceae are present in Abu 
Dhabi 
• To characterize such isolate(s) to establish the a l lel ic type of the enzyme 
produced and its genetic background 
• To col lect simi lar isolates from cow1tries of the Arabian Peninsula 
• To compare their 
o susceptibi l ity patterns 
o type of V I M  produced 
o its genetic background 
o plasmids carrying the blavrM genes 
o genes coding for resistance to drugs other than carbapenems 
• To establ ish their c lonal relationship 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
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I I I . M ATE R I A LS A N D  M ETHODS 
1 1 1 . 1 .  Bacterial Stra in  
The ubject of the first part of our study was an Enlerobacter cloacae strain 
( BC 1 04) identified to carry blaYIM from a col lection of 34 carbapenem resistant 
Enterobacteriaceae submitted to our laboratory between 2009 and Apri l 20 1 2  from 
th nited Arab Emirates to confirm the presence of any carbapenemase genes. 
For the second part of the study, altogether 1 66 i ndependent 
Enterobacteriaceae isolates isolated between 2009 and Apri l ,  20 1 3  from Kuwait, (27 
isolates: Prof. V incent Rotimi and Dr. Wafa Jamal,  Kuwait University, Kuwait), the 
Kingdom of Saudi Arabia (54 isolates: Prof. Atef Shibl, King Saud University, 
Riyad), from the Sultanate of Oman (63 isolates: Dr. Seif Al-Abri and Dr. Aminah 
AI-Jardani, Royal Hospital, Muscat), and further 22 isolates recovered between May 
20 1 2  and Apri l ,  20 1 3  from the United Arab Emirates were examined. I solates of the 
latter group were received mostly from different Abu Dhabi hospitals, while a few 
others were obtained from Sharjah and Dubai . Al l  strains were chosen on the basi s  of 
showing decreased susceptibil ities to any of the carbapenems tested by any of the 
methods used by the isolating laboratories according to the CLSI  standards val id at 
the time of their i solation. Once received, their susceptibil ity was confirmed (see 
later) and only those 1 66 isolates, which exhibited decreased susceptibi l i ty to any 
- 44 -
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carbapenems by the current CL I tandards eCL I 20 1 2) were included into the 
col lection. creening of these identified 1 1  strains as carrying blavlM (see the 
de cription of the P R reaction later), which were the subject of our subsequent 
work. trains were speciated by the providing laboratories. Once the susceptibil ities 
were confirmed. strains were stored in 20% glycerol at -80 °C in duplicates, in two 
freezer connected to two independent electric c ircuits. 
1 1 1 .2 .  Antibiot ic u ceptibi l ity Test ing 
During the first study ( i .e .  the identi fication of the first VIM expressing strain 
in the Gulf region) the quantitative susceptibil ity of the isolates and their derivatives 
were establ ished by E-test (BioMerieux) against imipenem, meropenem, ertapenem, 
ceftazidime, cefotaxim, cefepime, azrtreonam cefoperazone, trimethoprirnl 
sulphamethoxazole, chloramphenicol, amikacin, gentamicin, tobramicin, net i lmicin, 
c iprofloxacin. moxifloxacin, levofloxacin, tetracyc l ine, minocyc l ine and colistin. In  
a l l  subsequent studies antibiotic sensitivity testing was routinely performed by the 
Kirby-Bauer disk diffusion method using ampic i l l in, amoxic i l linfclavulanic acid, 
c iprofloxacin gentamicin amikacin, tobramycin chloramphenicol, tetracyc l ine, and 
trimethoprimfsulphamethoxazole discs purchased from MAST Group Ltd. 
Quantitative susceptibil ities to ceftazidim, cefotaxin1 ,  imipenem, ertapenem, 
meropenem and aztreonam were determined by the broth microdilution method. 
- 45 -
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I I  test were carried out and evaluated by the CL I standards (CL I 20 1 2) .  
For a l l  antibiotic sensiti i t  as  ays, Escherichia coli ATCC 25922 was used as  a 
u ceptible contro l .  ince for tigecyc l ine there are no current CLSI breakpoint values 
available, we u ed the ones recommended by EUCAST (www .eucast.orglcl inical-
breakpoints ). 
For the disc diffu ion test and E-test, fresh cultures grown on Tryptic-soy agar 
(T A) plates were suspended in steri le 1 xPBS to 0 .5  McFarland density and appl ied 
onto read -made Muel ler-Hinton agar (MHA) plates (Pangulf Lab Solution) with a 
swab. Antibiotic disks or E-tests were applied using a dispenser or sterile forceps. 
For the microdi lution assay, antibiotics were serial ly di luted in 1 00 J..lI volume 
in 96 wel l  microplates unc) and inoculated by a Multipoint inoculator (MAST) to 
give a final concentration of 5 x 1 05 colony forming units (CFU)/ml .  
i l 1 .3. Phenotypic Assays to Assess the Presence of Various Beta-Iactamases 
The double disc synergy test was used to confirm ESBL production using a 
disc containing amoxic i l l inlclavulanic acid placed in the center of the inoculated plate 
and discs containing various cephalosporins and aztreonam placed around 20 mm 
apart from the central disc . The strains exhibiting the "keyhole" were considered as 
an ESBL producer (Sonnevend et al .  20 1 3 ). 
- 4 6 -
VIM-type carbopenemoses Naur Yah/au/i, MSc Thesis, 2014 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
The general presence of carbapenemases were assessed b the modified 
Hodge te t (CL I 20 1 2) .  Muel ler Hinton agar plates (Pangulf Lab olution) were 
inoculated with a 0 .5  McFarland suspension of E. coli TCC 25922. Meropenem, 
ertapenem or imipenem usceptibi l ity di ks were placed on the center of the plate . 
The te t train a carbapenem susceptible negative control (E.  coli K- 1 2  J53)  and 
KPC producing po it i  e control (GR-KPC2) 'V ere treak-inoculated towards the disc .  
The plate was incubated 0 emight at 3 7°C . After 1 6-24 hours the plate was examined 
for a c lo erleaf-type indentation at the intersection of the test organism and the E. coli 
25922. 
The presence of specific carbapenemases was assessed based on inhibition by 
either phenyl boronic  acid (PBA) or by EDT A (Appl ichem).  The former one i nhibits 
C lass A and C, whi le the latter one c lass B i .e .  MBL enzymes. The test was 
performed by inoculating Mueller-Hinton agar plates as described for the standard 
d isc diffusion method and placing a disc of meropenem without any inhibitors, one 
wi th meropenem + 400 ).lg of PBA, and one with meropenem + 292 ).lg of EDT A. A 
minimum 5 rnm increase in  the diameter of the zone of inhibition in the presence of 
the inhibitor suggested the presence of the respective type of enzymes. In case PBA 
was found to be effective, the test was repeated in the presence of c loxac i l l in, as wel l .  
I f  i t  a lso showed efficacy, i t  suggested the involvement of AmpC type enzymes 
(Tsakris et a l .  20 1 0). 
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I I I . .. t E traction of Bacterial  Genomic D for PCR 
Three to  5 colonie of the bacterial strains grown overnight on T A plates 
w re picked b toothpick and su pended into two 200 III of steri le disti l led water in 
Eppendorf tube . The tubes were incubated for 1 0  minutes at 99°C in a thermo-block 
(Eppendorf). They " ere centrifuged for 1 0 minutes at 1 4,800 rpm; the supernatant of 
both tube wa col lected without touching the pel let, combined in a new autoc1aved 
Eppendorf tube and kept at 4°C. This material  was used for most experiments as the 
D target. Whene er doubts were raised on the qual ity of DNA material  (e.g. fuzzy 
amplicons, unexpected results), DNA was extracted using the QIAamp DNA Mini 
Kit (Qiagen) according to the manusfacturer's instruction. 
I I I .S. Genotyp ing by PCR 
Before submitting D A samples to further testing, a 1 6S PCR reaction was 
carried out to establ ish the presence of bacterial DNA (Louie et al .  2002). dNTP's 
used were from Applied B iosystem, whi le other reagents: 1 0X buffer with loading 
dye .. MgCh buffer Q and Taq polymerase were purchased from Qiagen. The U ltra-
pure dist i l led water was D Ase, RNAse free and was obtained from Gibco. The 
reactions were performed on Appl ied B iosystems 2700 and 2720 thermocyc1ers. In  
a l l  reactions E. coli J53RAZ genomic DNA and ultra-pure disti l led water were used as 
negative controls. Al l  positive reactions first obtained were confirmed by direct 
sequencing (see later). 
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1 1 1 .5. 1 .  P R Detection of Variou Beta-Lactama e Gene 
The targeted gene , the primers and parameters used in these PCR reactions 
"",ith re pective references are listed in (TABLE 4.). For AmpC genes detection a 
mUltiplex PCR (Perez-Perez and Hanson 2002) was used with six sets of ampC-
pecific primer gi en in (TA BLE 5.) .  In case of obtaining a CIT-l ike blaAmpc 
amplicon within the mpC gene-targeting PCR reaction the entire gene was 
amplified using flanking forward primer5 ' -AACACACTGATTGCGTCTGAC-3 ' 
and rever e primers. S " -CTGGGCCTCATCGTCAGTTA-3 ' (Perez-Perez and 
Hanson 2002). Al l  amplicons of the above PCR reactions were purified with a gel 
purification Kit (Promega) as directed by the manufacturer and sequenced directly 
( ee later). 
1 1 1 .5.2 .  Detection of Plasmid Mediated Q uinolone Resistance and Ribosomal 
M ethyltra nsferases Genes by peR 
Plasmid mediated target protection qnr genes were detected by a multiplex 
PCR (Cattoir et al . 2007). The two other plasmid mediated quinolone resistance genes 
qepA and aac-6 '-Ib-cr were detected by simplex PCR methods published earlier 
( Poirel et aI . ,  20 1 1 )  with primers l i sted in (TABLE 6.). The primers and parameters 
to detect armA, rmtA,  rmtB, rmtC, and rmtD and npmA are presented in (TABLE 7.) 
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1 1 1 .6. Detect ion of Pia m i d  
The alkaline I y  i method was used to determine the plasmid profile of  the 
i olates u ing the method of Kado and Liu with sl ight modifications ( Kado and Liu 
1 98 1 ) . The trains were inoculated on half TSA plates to obtain confluent growth and 
incubated 0 emight at 3 7°C. ext day, cel l s  were col lected with toothpicks from the 
plate, suspended gently  in 250 ) .. d of lysing solution (3% SD , 50 mM Tris, pH 1 2.56) 
to get a turbid suspension and mixed by gentle agitation unti l  the preparation became 
homogenou and viscous. To complete cel l  lysis, the suspensions were incubated at 
60°C in a thermo-block for 45 minutes whi le gently mixed manual ly every 1 5  
minutes. 250 ,u l  of phenol -chloroform ( 1 :  1 )  was added and by gentle shaking the 
mixture was l iquefied. Centrifugation at 1 3 ,000 rpm for 1 5  minutes separated the 
layers. The top aqueous layer (approximately 60 ,u l )  was transferred to c lean tubes 
containing the loading dye without disrupting the prec ipitate at the interface ( i .e. 
without touching the floating pel let). Samples were subjected to electrophoresis for 7 
hours at 1 20 V in 0.8% agarose gel (Sigma) and I X  TBE. The gel was stained with 
ethidium bromide (EtBr) for 20 minutes, fol lowed by de-staining for 1 0  minutes in 
400 rn1 of Mi l l iQ water with gentle  shaking. Bands were detected in a Biometra UV 
transi l l uminator. Plasmids i n  39R86 1 ( 1 54kb, 66.2kb, 37 .6kb and 7.4kb) were used as 
plasmids molecular size controls, and E. coli J53RAZ i .e .  a strain containing no 
plasmids, served to aid the identification of the chromosomal band. 
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1 1 1 . 7. Detect ion of Megapla m id by 1 N uclea e Dige t ion 
This method i u ed to detect ery large pIa mids (Barton et a1. 1 995, Basta et 
a1 .  2004). trains were grown overnight in 1 5  ml TSB with or v ithout 8flg/ ml 
ceftazidime at 37° C.  Ne t da , approximately 4 x l 09 cel ls were col lected by 
centrifugation. The cel l s  were washed and re-suspended in 500 fll of EC buffer ( 1 0  
m M  Tris, 0. 1 M EDTA, 1 M aCI pH8.0) .  To 5 ml of melted plug agarose (Sigma), 
l O)ll of RNase ( 1 0flg/ fl l )  (Qiagen) was added. 500fll of the melted agarose was 
mi ed with SOOfll of the bacterial suspension and immediately transferred to 1 ml  
synnges. fier sol idifying, the plugs were cut into 1 mm thick s l ices. The agarose 
plugs were incubated in 1 ml of EC buffer containing 20 flg/ ml RNase and 1 mg/ml 
lysozyme to lyse the cel l s  within. Subsequently, the p lugs were incubated at SO°C 
overnight in ES buffer (O. S M  EDTA : l %  N-Iaurylsarcosine) buffer supplemented with 
I mg/ml proteinase K ( Invitrogen). The ES buffer and the proteinase were inactivated 
by washing the plugs in I ml of l rnM phenylmethylsu lfonyl fluoride (PMSF, Sigma) 
prepared in  TE buffer. I n  order to l inearize the circular megaplasrnids the plugs were 
washed twice in 1 mL 1 0m M  Tris pH8.0 for 1 5  min at room temperature fol lowed by 
digestion with 1 Unit of S I  nuclease in 200 fll of S l  buffer for 1 0  min at 3 7°C. S I  
nuclease mixture was removed and replaced with cold ES buffer and the tubes were 
incubated on ice for 1 5  min .  The plugs were loaded into wel l s  of 1 % horizontal 
agarose gel s  prepared in (O .SXTBE). Lambda Ladder PFG Marker (New England 
BioJabs) was used as size marker. The gel loaded was placed into the electrophoresis 
chamber of C HEF Mapper (Biorad). E lectrophoretic conditions were the fol lowing: 
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6V fcm current with 1 8  hours run time and 1 20· angle with 5 sec initial to 25 sec final 
witch time \ ith l inear ramp. 
1 1 1 .8. PIa m id Repl icon Typing 
PIa mid are c lassified based on their incompatibi l ity ( I nc) groups (Datta and 
Hedges 1 97 1 ,  ovick 1 987) .  Plasmids with the same repl ication control genes are 
incompatible, i .e .  cannot co-exsist in the same cel l (Datta and Hughes 1 983, 
Couturier et a1 . 1 988) .  Traditional ly incompatibil ity groups were establ ished on 
basis of the incapacity of two plasmids (one of a known Inc group) to coexist within 
the same host cel l  (Anderson et a1. 1 977). Lately, it has been done by determining the 
equence of the plasmids' repl icons, initially by hybridization with a set of probes 
(Couturier et a1. 1 988)  and today mostly by PCR (Gotz et a1 .  1 996). 
Template DNA was prepared from bacterial col lections using a boi l ing lysis 
procedure, as previously described. We targeted 1 8  different repl icons, i .e. PIA FIB,  
F IC,  H l 1 ,  H I2,  l l - Iy, LIM, N, P ,W T, AlC, K, B/O, X Y F,  and FI lA,  respectively, 
by PCR assigned into 5 m ult ip lex, and 3 simplex reactions (Caratto l i  et a1. 2005). 
The primers and the parameters used are shown in (TABLE 8. - see page 58). 
I n  addition to the original typing set, the recently identified I ncHl l B repl icon 
type was sought by simplex PCR reaction (Dortet et a1. 20 1 2) .  Primers and conditions 
used are cited in the (TAB L E  8.) .  
- 5 6 -
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Four simplex PCR reaction were perfonned to screen for the IncX plasmid 
ubgroup (Johnson et al. 20 1 2).  Primers and conditions used are cited in (TABLE 
8). P R wa perfonned u ing the arne conditions for al l  simple PCRs. 
1 1 1 .9. Conj ugation 
For conj ugat ion experiments, J53RAZ (Na-azid resistant in-house derivative of 
the rifampin resistant J53 E. coli K- 1 2) were used as recipients. Conj ugation was 
attempted by combining cultures of the donor and recipient in 1 : 5 ratios, for 4 hours 
at 3 7°C without shaking, and then it was centrifuged at 3 500 rpm for 1 5  minutes. The 
upematant was removed and the pel let was re-suspended in 200 /-ll TSB and 1 00 II I 
of the su pension was added as a drop to the center of a TSA plate without any 
antibiotics (2 plates were prepared). Next day, the growth of both plates was col lected 
in PBS. After centrifugation at 3 ,500 rpm for I 5  min, the pel let was washed and re-
suspended in 3 ml of PBS.  Serial di lutions of - 1 ,  -2, -3 were prepared and al iquots of 
200/-ll were plated onto plates containing 1 00 Ilglml Na-azid and 8 mgIL ceftazidime. 
ext day, colonies were col lected and subjected to repeated antibiotic susceptibi l ity 
tests, plasmid  electrophoresis, PCR and in case of necessity, to ERIC PCR and PFGE 
to ensure that transconj ugants and not mutants of the donor or recipient were 
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1 1 1 . 1 0. Tran format ion 
If we were unable to mobi l ize the blavfM -carrying plasmid into an E. coli K-
1 2  recipient tran formation of the pIa mid was attempted. For these experiments E. 
coli DH5a v as used as a rec ipient. Plasmid DNA was purified by the method of Kado 
and Liu (Kado and Liu 1 98 1 ). The procedure described above for plasmid detection 
wa continued b removal of traces of phenol from the aqueous preparations 
normally u ed for e lectrophoretic detection of the plasmid by mixing the solution 
',: ith an equal volume of chloroform, and centri fuged at 1 5 .000 rpm for S min. The 
aqueou layer was col lected into a new tube, 1 :  1 0 volume of sodium acetate (PH 5 .2)  
v as added fol lowed by 3 volumes of 99% ethanol .  The preparation was incubated at 
-80°C for at least 30  min and centrifuged at 1 5000 rpm for 30min at 4°C. The pel let 
was washed with 1 ml of 70% ethanol and centrifuged at 1 5000 rpm for 1 0  min. After 
air-drying, the pel let was resuspended in TE buffer ( 1 0mM Tris :  I mM EDTA pH8 
( igma) . For re-purification, the same steps were fol lowed without adding 
chlorofonn. Five Ilg of D A,  as measured on a ND- l 000 spectrophotometer (Nano 
Drop Technologies, USA) were used for every transformation. 
Bul lets of 1 50 ilL competent E. coli DH5a cel ls  were used for heat shock 
transformation. Cel ls  were made competent by calcium chloride method. E. coli 
DHSa was grown at 3 7°C in  shaken culture in Luria-Bertani broth t i l l  OD600 reached 
0 .S-0 .7, centrifuged at 5000rpm for 1 0  min at 4°C, resuspended in cold SOmM CaC12 
on ice centrifuged at 5000rpm for 1 0  min at 4°C, resuspended again in  cold 50mM 
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a h on ice, left on ice for 20 min, centrifuged at 5000rpm for 1 0  min at 4°C, 
reu upended in 50mM Ca h containing 20% glycerol ,  al iquoted in 1 50111 and snap 
freezed in l iquid l iquots were stored at -80°C . Heat shock transformation was 
accompli hed by putting the mixture (puri fied D and competent cel ls) on ice for 
two minute ; then a thermo-block was u ed for heat shock at 42°C for 5 minutes and 
final ly the preparation was left on ice for two minutes. The transformation mixture 
was incubated either for I h  or 0 emight at 37 °C with shaking· then it was plated 
onto plates containing 8 l1g1mL ceftazidime. The type of plasmid content of 
transformants was confirmed by electrophoresis susceptibil ity testing and PCR. 
1 1 1 . 1 1 . Hybridization 
Plasmid gels were depurinated in 0.25 M HCI, fol lowed by denaturation in  0 .5  
M aOH, 1 M aCl and final ly neutral ized in 1 M Tris, 0 .6  M NaCl .  Al l  treatment 
steps were 1 5  minutes long at room temperature with gentle shaking and were 
repeated twice. Between each step gel s  were rinsed in  sterile disti l led water. The gel 
was capi l lary-transferred to Hybond N+ membranes ( Roche) by soaking overnight in 
20X SSC (Sal ine Sodium c itrate). Next day the membranes were UV cross-linked at 
70 000 micro-joules. 
Hybridization probes were generated by PCR ampl ification of blaYIM-4, 
I ncA/C, I ncN, blaTEM- l ,  blacMY-4 , blaCTX-M- I S  of genomic DNA of control strains, 
fol lowed by DNA purification (Promega Kit), and quantitation using the ND- I 000 
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spectrophotometer ano Drop Technologies, U A). The D A fragments were 
labeled u ing the DIG D A label ing kit ( Roche). In  brief, 200 ng of purified 
fragment wa boi l d fI r I O minutes in a boi l ing water bath and quickly chi l led on ice. 
The denatured D was conjugated ith digoxigenin according to the 
manufacturer in truction . Membrane were pre-hybridized at optimal hybridization 
temperature, \ hich was calculated based on the size of the probe and GC ratio, using 
the fonnula recommended by the manufacturer. (Topt.=T m-20°C with 
T m=49. 82+0A I (%G+C)-600fL (L=length of the probe in base pairs)) in a pre-
anned hybridization buffer (SX SSC 1 % blocking solution, 0. 1 % N-lauryl 
arcosine, 0.02% SD ) for 30 minutes fol lowed by the addition of the hybridization 
buffer containing the probe. According to the previous calculations the membranes 
were hybridized overnight with gentle shaking at 69°C for VIM,  70°C for IncA/C, 
68°C for Inc , 7 1 °C for blaCMY-4, 72°C for CTX-M- 1 S , and 69°C for TEM- l .  
For post hybridization, the blots were washed twice with 2X SSC / 0 . 1 % SDS 
(Sigma) at room temperature C RT) for S minutes with gentle shaking fol lowed by two 
subsequent washings in 0 . 1 X SSC / 0. 1 % SDS at 68°C for I S  minutes also with 
constant agitation. The membrane was briefly rinsed in washing buffer at room 
temperature, incubated in blocking solution for 3 0  minutes, and again incubated in  
antibody solution provided with the k i t  for 30  minutes. The blots were washed twice 
in washing buffer equi l ibrated in detection buffer and fi nally incubated without 
shaking in the color substrate solution for various lengths of time in the dark ti l l  the 
desired spot or band intensity was seen. The reaction was stopped using TE buffer 
- 6 2  -
VIM-type carbapenemases Naur Yah/auf;, MSc Thesis, 2014 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
( 1 0mM Tris :  1 mM EDT pHS ( igma)). The blot was digitized using the Biometra 
gel documentation system. In order to re-probe the membrane, it was stripped with 
dimethyl formamide at 56°C fol lo\: ed by steps starting from the pre-hybridization. 
I I I . 1 2 . M acrorestriction of the Chromosome Followed by Pulsed Field Gel 
Electropho re i ( PFG E) 
In  th is  technique a restriction endonuclease with rare cutting sites (XbaI) was 
appl ied to digest the entire bacterial chromosome embedded into agarose gel plugs to 
protect D A from mechanical fragmentation. The very large DNA fragments 
generated by enzymatic digestion were electrophoretical ly separated in an electrical 
field with changing vector of the current (Gautom 1 997) .  The pattern of the fragments 
pro ided the basis of comparison. 
Bacterial strains grown on TSA plates were suspended in 2ml of cel l  suspenSIOn 
buffer ( 1 00mM Tris :  1 OOmM EDTA pHS.O) up to a density of 3 McFarland unit. 
Suspensions were kept on ice. Simultaneously, 1 % plug agarose (Sigma) was melted 
in 1 %  SDS in TE buffer ( l OmM Tris : l mM EDTA pH8 .0)  and kept at 54°C. 500 fll 
bacterial suspensions, 25 fll of proteinase K ( I nvitrogen) (20 mg/ml )  and 525 fll of 
1 % plug agarose were combined, mixed careful ly, quickly transferred into 1 ml 
syringes and kept for 1 5-30 minutes at room temperature to al low the sol id ification of 
the agarose. Al iquots of 5 ml  cel l  lysis buffer (50mM Tris :50mM EDT A pH8 .0, 1 %  
Sarkosyl )  and 2 5  fll proteinase K 20 mg/mL were distributed into 50 ml tubes and 
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I mm thick l ices of agarose plugs were directl cut into them. They were incubated 
for 2 hours at SO·C in a shaker water bath (200 rpm).  Subsequently the plugs were 
washed twice \ ith 1 0  ml of preheated steri le Mi l l iQ water for 20 minutes in a SO·C 
haker water bath. Plugs were wa hed four times for 20 minutes with 1 0  rnl of 
preheated TE buffer. Finally plugs were stored in 5 ml of fresh TE buffer at 4 ·C.  
Genomic D A within the plugs were digested overnight at 3TC in a 1 00 �l 
restriction mixture made of 1 0 �l of NE buffer 4 (New England Biolabs), 1 �l of BSA 
ew England Biolabs), 30 U ( l . 5 �l) of XbaJ enzyme (New England Biolabs) and 
87 .5  � l  of sterile disti l led water. Fol lowing digestion, the restriction mixtures were 
removed and the plugs were incubated in 250 �1 of 0 .5X TBE buffer for 30  minutes at 
room temperature. Subsequently plugs were inserted into wel ls  of 1 .4% of agarose 
gel (pulse Field Running Agarose A2929, S igma) prepared in 0.5xTBE buffer. The 
two wel l s  at the two sides of each gel s  contained a lambda-ladder PFGE marker (New 
England B iolabs) for standardization. Gels were run in CHEF Mapper (Biorad) 
e lectrophoresis chamber in 0 .5X TBE buffer pre-chi l led to 1 4°C.  The running 
program consisted of 26 hours rill1 at 6 V/cm with 1 200 angle and an initial switch 
time of 2 .2  seconds and a final switch time of 54.2 seconds with l inear ramp. 
The gel s  were stained with ethidium bromide for 20 minutes fol lowed by de-
staining in Mi l l iQ water. Bands were detected and photographed under UV l ight in a 
B iornetra gel documentation system. Gel pictures were stored as .tif files for further 
analysis. The GelCompare I I  software (Appl ied Maths, Sint-Martens-Latem, 
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Belgium) v a u ed to analyze the banding patterns. The Um eighted Pair Group 
Method with ritlunetic Mean (UPGM ) tree graphica l ly sho ing the level of 
relatedness between the isolates was created based on the Dice similarity coefficient 
( D) (Dice, with a 1 . 5% po ition tolerance). trains showing patterns with SD � 80% 
were arbitrari ly considered to represent a pulsotype. 
1 1 1 . 1 3. M ulti locu Seq uence Typing of Selected Strains  (M LST) 
Al l  strains were subj ect to a spec ies-spec ific MLST protocol usmg their 
genomic D A.  The primers used are l i sted in « TABLE 9.) - see page 67). PCR 
product was purified according to the manufacturer' s instruction with PCR and gel 
purification kit ( Prom ega) and both strands were directly sequenced using a 3 1 30X 
genetic analyzer (Applied Biosystems). The sequence results were analyzed using 
MEGA5 program (Tamura et a 1 .  20 1 1 ). 
For E. coli the MLST protocol of Wirth el af. was used (Wirth et a1 .  2006). The 
i solate was then assigned to sequence types using the tools on the E. coli MLST 
webpage (http://mlst .ucc . ie/mlstJdbs/Ecol i ) .  E. cloaceae was subjected to the MLST 
protocol of (Miyoshi-Akiyama et a 1 .  20 1 3 ) .  Sequence types were determined 
according to the E. cloaceae MLST webpage (http://pubmlst.orglecloacael). For K. 
peumoniae the protocol of (Diancourt et a 1 .  2005) was appl ied and K. pneumon;ae 
MLST webpage 
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Chttp://W"\\w.pasteur. fr/recherche/genopoleIPF8/mlst/Kpneumoniae.html) was used to 
establi h the sequence types. 
I I I . H. E RIC PCR 
The Enterobacterial Repetiti e Intergenic Consensus Polymerase Chain 
Reaction (ERIC-PCR) (Versalovic et a1. 1 99 1 )  method was used to rapidly confinn 
difference between donor, rec ipient for conjugation and or transfOlmation. I t  was 
perfonned b using the ERIC2 primer ( 5 ' -AAG TAA GTG ACT GGG GTG AGC G-
3 ' ) .  7 -minutes initial denaturation at 94°C was fol lowed by 30  cycles of 
denaturation for 30seconds at 90°C, annealing for 60seconds at 50°C and extension 
for 8 minutes at 65°C.  The final step was an extension for 1 6  minutes at 65°C. The 
patterns obtained with different strains ( strictly ampl ified in the very same experiment 
only) were compared visual ly .  
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1 1 1 . 1 5. haracterization of the G enetic E nvironment of blaVDI-4 
The genetic support of biavlM-4 was determined by PCR mappmg and 
equencmg using primers de igned based on the genetic surrounding of blovfM 
published earl ier (GenBank accession numbers AJ704863 and A Y339625) .  (Miriagou 
et al . 2004, Col inon et al .  2007). Al l  primers used for sequencing were designed with 
the help of C lone Manager v9.2 ( ci-Ed Software, Cary, C, US). Primers amplified 
overlapping fragnlents of the molecular structure surrounding blavrM, which were 
sequenced with the ampl ification primers and with walking primers annealing 
appro. imately 500 bp apart. Al l  PCR reactions were performed using 3 5  cycles of 30' 
94 °C denaturation fol lowed by 55  °c annealing for 1 min and extension at 72 °C for 
varying length of time ( 1 '-3 ') depending on the size of the expected products. peR 
and sequencing primers are l i sted in  (TABLE 1 0. ) .  Sequencing of ampl icons was 
performed with the Big Dye Cycle Terminator V.3 . l (Applied Biosystems) using the 
3 1 30X Genetic Analyzer (Applied Biosystems). After checking the quality of the 
equencing trace files with MEGA5 .0, the sequence fragments were al igned and the 
complete genetic surrounding was constructed using the Clone Manager v9.2 (Sci-Ed 
Software, Cary, NC, US) .  Annotation and GenBank deposition of the sequences was 



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































I V. RES U LTS 
I V. 1 .  VI M-Prod ucing Ellterobacteriaceae i n  Abu Dhabi 
creenmg a col lection of 34 carbapenem non-susceptible c l inical 
Enterobacteriaceae isolated in bu Dhabi Emirate for various carbapenemase genes 
identi fied an Enterobacler cloacae strain positive for blaVlM (ABC 1 04). 
ABC I 04 was resistant to Imlpenem (MIC= 1 6  mg/L), meropenem 
(MIC=8mglL), ertapenem (MIC=4mglL), ceftazidime (MIC> 1 28mg/L), cefotaxim 
(MIC> 1 28mglL), cefepime (MIC=64mg/L), aztreonam (MIC> 1 28mg/L), 
cefoperazone (MIC=64mglL), trimetoprime/sulphametoxazole (MI C=8176mg/L), 
chloramphenicol (MIC=32mg/L), gentamicin (MIC=32mg/L), tobramycin 
(MIC=48mg/L), neti lmicin (MIC=32mg/L), c iprofloxac in (MIC=32mg/L), 
moxifloxacin (MI C= 1 2mglL) levofloxacin (MIC= 1 2mg/L), tetracycl ine 
(MIC=64mg/L),  minocycl ine (MIC=32mg/L) and exhibited sensitivity to amikacin 
(MIC=6 mg/L) and colistin (MIC=0. 1 25mg/L) only.  I t  carried the blaYlM-4 gene on an 
I ncAiC type plasmid of approximately 1 75 kb of size as detected by Southern blotting 
of the S l  digested genomic DNA (F IGURE 8.). ABC I 04 also harboured other �­
lactamase genes:  blacTx-M- 1 5, blaTEM-l and blacMY-4, as wel l ,  with blacMY-4 being 
located on the same plasmid as blaYlM-4 . The blaCTX-M- I S  gene was carried on a 
plasmid of approximately 300 kb size, while a probe for blaTEM-l hybridized with 
both plasmids ( F I G U RE 8.) . 
- 7 2  -
( kb )  
3 39 . 5  
2 9 1  
242 .5  
194 
145 .5  
97 
485 
Gel V I M  TEM CTX-M CMY-4 I ncA/C 
FIGURE 8. Southern blot of the S I d igested genom ic  DNA of E. cloacae 
ABC I 04. Ge l ,  left lane: A concatamer. 
Spec{ficit)' a/the probes used are shown above the membrane strips 
Attempts to conj ugal ly transfer the blavlM-4 carry ing p l asmid into an azid 
res i stant derivative of E. coli J 5 3  fa i led at 30°C, as \\ e l l  as at 3 7°C . Transfonnat ion of 
competent DH5a \\l ith p lasm id  preparation of w i ld  type ABC 1 04 was a lso attempted. 
but \1, as unsuccessfu l .  
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The blo\ IM-4 \\ a ident i fied as part f a c ia I integron b) P R mapping and 
equenc ing ( F I G U R E  9.) .  
mtl1 blalll 04 • aacA 7 
FIGURE 9. Be I 04 blavl 1-4 bearing c i a  s 1 integron 
qacE.J:l1 su/1 ori5 
I V.2.  V I M-Prod uc ing Ellterobacteriaceae i n  Fou r  Coun tries of the Arabian 
Pen i n  u la 
creening the second col lection of further 1 66 i o lates ident ified I I  stra ins  
pos i t i \ e  for bla\ IM . Their  names. pec ies and country of origin are l i sted in (TABLE 
1 1 . ) .  The prev a lence of V I M  producers was 29.6% in  Kuwait  (n=27).  3 . 1 % in the 
u ltanate of Oman ( n=63). 1 . 85% in  the K ingdom of Saudi Arabia ( n=54)  and 1 . 79% 
in the E ( n=56) .  
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TABLE 1 1 . IM-produ ing Enterobacteriaceae of the Arabian Peninsula 
Strain Species Cou n t ry of isolation 
KW I Klebsiella pneumoniae Kuwait 
KW2 Kleb iella pneumoniae Kuwait 
KW3 El1lerobacler cloacae Kuwait 
K W4 Klebsiella pnellJnoniae Kuwait 
KW6 Klebsiella pl1elll11oniae Kuwait 
K W7 Escherichia coli Kuwait 
KW8 Klebsiella pnelll110niae Kuwait 
KW l l  Klebsiella pnelll1loniae Kuwait 
OM63 Enterobacter cloacae Sultanate of Oman 
OM69 Enlerobacler cloacae Sultanate of Oman 
SA4 2 Enlerobacter cloacae K ingdom of Saudi Arabia 
ABC 1 04 Enterobacler cloacae United Arab Emirates 
I V.2. 1 .  Ant ibiotic Susceptibi l ity Test ing 
All strains exhibited resistance to all  carbapenems and third generation 
cephalosporins tested. Modified Hodge test was positive with al l  isolates and EDT A, 
but not PABA exhibited synergy with meropenem in all cases. Al l  but E. cloacae 
412, were resistant to aztreonanl, which suggested of co-harbored ESBL or AmpC 
cephalosporinase enzymes in the other 1 1  isolates. Strains were uniformly resistant to 
tobramycin, co-trimoxazole and tetracycl ine. Susceptibil ity to ciprofloxacin, 
chloramphenicol ,  gentamicin, amikacin and tigecycl ine (using the EUCAST 
breakpoints) were variable. Only one K pneumoniae (KW l 1 )  exhibited resistance to 
colistin. Detai led susceptibi l ity data are shown in TABLE 1 5. 
I V.2.2. Detection of Non-Carbapenemase Coding Antib iotic Resistance Genes 
The results of 2 1  d ifferent PCR reactions targeting common ESBL, AmpC 
cephalosporinase, plasmid mediated quinolone resistance and ribosome methylase 
genes as wel l  as their alleles identified by sequencing are l isted in TABLE 1 2. 

























































































































































































































































































































































































































































































































































































































I V.2.3. �lo1ecular Typing of V I M  Producer I olate 
I I  tra in  carried the bla\ IM� al l  Ie a proven b) equenc ing of the blavlM 
ampl icon . PFG E t) ping of the train shovv ed that \\ ith the e cept ion of two K. 
pnelllllOlllae from Ku\\ a it ( K W I and K W2) and the 1"\,\ 0 E. cloacae from Oman. the 
tra in  \\ ere not related ( FI G U R E  1 0. and 1 1 . )  -belC\\ . 









F I G UR E  1 0 . PFG E com parison of K.pneZimoniae carry ing V I M -4 
Dice ToI 1 5%- 1 5% ) I H>0 0"'" S  0 00,01 [0 0%-100 0%J 
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F I G URE 1 1 . PFG E comparison of E. cloacae carry ing V I M -4 
The re u l t  of the mu l t i- locus sequence typ ing of the 1 2  V I M -4 producer 
stra ins  is  sho\v n in  (TA BLE 1 3.) .  I t  i s  i nteresting  to note that a lthough OM63 and 
- 77 -
M69 ",,, ere onl 70% imilar to ABC I 04 by PFGE, their sequence type was the 
am . Further cIu tering by ML T was only observed with strains KW I and KW2, 
which were already grouped together by PFGE. 
TA B L E  1 3. 11 l ic  profile and T of V I M  -4 producer isolates 
Strain  Allel ic profile 
E. coli 
adk fumC gyrE icd mdh purA 
KW7 1 0  1 1  4 8 8 1 3  
E. cloacae 
filluA flisA gyrB leuS pyrG rplB 
K W3 4 4 4 6 92 30 
A BC 1 04 49 20 1 9  44 90 24 
OM63 49 20 1 9  44 90 24 
OM69 49 20 1 9  44 90 24 
SA4/2 82 56 93 93 9 1  4 
K. pnelltnolliae 
gapA illfB mdh pgi pilOE rpoB 
K W 1  4 1 1 24 I 7 4 
K W2 4 1 1 24 1 7 4 
K W4 1 8  22 26 23 3 1  1 3  
KW6 1 7  1 9  39 1 1 2 1 22 1 8  
KW8 2 J 1 1 9 1 





2 ST l 67 
rpoB 
6 ST l 84 
32 ST 1 82 
32 ST 1 82 
32 ST l 82 
23 ST 1 83 
(ollB 
9 1  ST 1 399 
9 1  ST l 399 
49 ST 1 38 
1 48 ST 1 400 
4 ST I 40 1  
38  ST 1 47 
I V.2A. Local izat ion of the blav l �t-4 Gene 
The outhern blot of plasmid electrophoresis of the c l inical isolates was 
hy bridized with VI M-4 probe to pro e its local ization ( F I G U RE 1 2.) .  The size of 
plasmid that the probe hybridized with was approx . 1 75 kb in KW 1 ,  KW2, KW4 
KW6, KW7, KW8 and ABC 1 04, >300 kb in KW 1 1 ,  approx. 80 kb in KW3 and 
approx. 50 kb in OM63. OM69 and SA4/2. 
I V.2 .S. PIa m id Replicon Typing of VI M-4 Producer Clinical  I solates 
The results of the PCR based repl icon typing (PBRT) are shown below in 
(TABLE 1 4.) .  ince the majority of strains harbored IncAiC plasmids known to 
frequently  carry V IM genes, as wel l  as blacMY-4 the membrane used to localize 
blaVrlvl-4 v as re-probed with both IncAiC and blacMY-4 probes. These hybridizations 
proved that, beyond E. cloacae ABC 1 04, in K. pneumoniae KW 1 ,  KW2, KW4, 
KW6 KW8, KW 1 1 and in E. coli KW7 blavfM-4 was co-localized with blacMY-4 on 
Inc C plasmids (FIG U RE  1 2.) .  
TABLE 1 4. The incompatibi l ity types of plasmids detected in VIM-4 producer 
c l i nical i solates 
Strain I ncompat ibi l ity G rou� 
KW I IneAlC lneN lneFI lA  
K W 2  l neAlC lneN IneFl LA 
K W3 Non-typable 
KW4 lneAlC lneFl LA 
KW6 IneAlC IneHI l B  
K W7 l neAlC lneF IneFfB 
KW8 I neAlC 
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I V.2.6. Conj ugation and Tran formation of the bla\"D1� Carrier Plasm id 
Conj ugati e transfer of plasmid carrying blavIM-4 into the E. coli J53RAZ strain 
was attempted ith the 1 2  c l inical isolates at 3 7°C and 30°C which resulted in seven 
tranconj ugants: from 5 K. pnewnoniae (KW 1 ,  KW2, KW4, KW6, KW8), one E. coli 
(KW7) and one E. cloacae (SA4/2) only. 
From the five c l inical isolates from which the conjugation had fai led, 
plasmids purified were used to transform DHSu. Vl M-4 carrier plasmids were 
transformed from E. cloacae OM63 and OM69 into DHSu, while from K. 
pneumoniae KW l 1 and E. cloacae ABC I 04 and KW3 the transformation was 
unsuccessfu l .  
Antibiotic susceptibi l ity of  al l wild-type (WT) and respective transconjugants 
(TC) or transformants (TF) are l isted in (TA BLE 1 5.) .  
PBR T and hybridization confirmed the presence of lncAiC plasmid in 
J3SRAZ(pKW41 1 ), JS3RAZ(pKW6/2), J53RAZ(pKW7/9) and JS3RAZ(pKW8/7). 
Transconj ugant JS3RAZ(pSA4/21 1 3 ) and the two transformants DHSu(POM63/T I )  and 
DH5u(pOM69/TS) were non-typable by PBRT. Al l  these plasmid had the same size 
a the V IM-4 plasmids in  the corresponding c l inical isolates (F IG URE 1 3.) .  
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Tran conjugant r3Rv (pKW 1 /3 )  and r3RAl (pK W2/9) harboured pia m id 
increa ed in  ize compar d to  the  V I M -4 p ia m ids  in  the  respect i  e c l in ical  isolate . 
and the tranconj ugant v. ere po i t ive for both the J nc Ie and I nc t) pe P R in the 
PBRT. outhem blot of ,\ i l d  ty pe and tran conj ugants , eri fied that increa ed size 
p ia  m Id in  J 53RAl (pK W l /3 ) and J 53RAl ( pK W2/9) \ ere the result  of fusion and co­
conj ugation of the e t\', o incompat i b i l i ty t) pe p ia m id ( FIGURE 1 4) .  
blan,I Y v, a amp l i fied from tran conj ugants J 53RAZ( pKW 1 /3 ). 
J 53R,v( pK W2/9). J 3 5R\l(pKW4/ 1 ). J 5 3 RAZ(pK W6/2). J 5 3RAZ( p K W 7/9) and 
r 3 RAl( p K W 817). i .e .  from tho e the I ncAle plasmid ,,, ere conjugated to. peR did 
not detect any of the other B- Jactamases, PMQR or r ibosomal methy l ase genes in any 
of the tran conj ugant or transformants. 
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FIGURE 1 4. K W I and K W2 V'r i ld -type and transconjugants p lasm id gel and 
respect ive hy brid izat ion v. i th V IM -4 (A) .  I ncAle (8) and I nc probes (C)  
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
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I V.2 .7. Genetic urrounding of blan \(-4 Gene 
PCR mapping and sequencmg of the molecular structure surrounding the 
bla IM-4 revealed c lass I integron structures similar to the one of E. cloacae ABC l 04 
(GenBank ccession o. JX275775) .  Comparison of this c lass I integron is shown in 
( F I G U R E  1 5. ) .  
The structure marked by (A) corresponds to  JX275775 and was found not 
only in ABC I 04 but in E. cloacae SA4/2 isolated in Saudi Arabia as wel l .  PCR 
mapping the c lassical 3'  end of c lass I integrons did not yield an amplicon in  any 
train isolated in Kuwait (KW 1 ,  KW2, KW3, KW4, KW6, KW7, KW8 and KW 1 1 ), 
so in  these isolates we identified a structure (B) which is identical to In4 1 6  described 
in a K. pneumoniae isolated in I taly (GenBank Acc. No. AJ704863). In E. cloacae 
OM63 and OM69 sequencing re ealed a c lass I integron simi lar to JX275775,  but 
lacked the dhfrI and LJaadA I gene casettes (C) .  
IV.2.8. Compa rison of All  VI M-4 Producer Strains I nvestigated 
A comprehensive assessment of a l l  features of VIM-producer 
Enterobacteriacae investigated in this study is given in TABLE 1 6. 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - _ . _ - - - - - - - - - - - - - -
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V. D I  CUSS I ON 
Enterobacteriaceae harboring metallo-beta-Iactamases are considered a 
serious, global ly evol ing threat to carbapenem antimicrobials, which represent the 
la t l ine of antibiotics that are sti l l  effecti e for treating many enterobacterial 
infections ordmann and Cornagl ia 20 1 2). Although, V IM-type metallo-beta-
lactamases has mostly been described in P. aeruginosa, they occurred in 
Enterobacteriaceae (Nordmann et al .  20 1 I a) .  The expression of blaYfM genes confers 
resi tance to all p-lactams except aztreonam, but their efficiency is dependent on the 
enzyme variants. V IM-4, a single amino acid variant of V I M- l , hydrolyzes imipenem 
and meropenem more efficiently than VIM- I (Lassaux et al . 20 1 1 ) .  Despite the 
enzyme efficiency, V IM- 1 producer Enterobacteriaceae, especially K pneumoniae 
has become widespread in some Southern European countries, i .e .  Greece, I taly and 
pain (Peirano Gisele). V I M-producing K pneumoniae has given rise to major 
problems both with respect to infection control and treatment in these countries 
(Daikos et al . 2009). 
ince its first description in  2002, VIM-4 has been identified in K 
pneumoniae, E. cloacae, Acinetobacter spp. A. hydro phyla and E. coli (Luzzaro et 
al. 2004, Ktari et al. 2006, L ibisch et al .  2006, Ikonomidis et al. 2007, Figueiredo et 
al. 2008, Kristof et al. 20 1 0, Juhasz et al . 20 1 2, Shevchenko et al. 20 1 2, Dimude and 
Amyes 20 1 3 . Jamal et al. 20 1 3 , Melegh et al . 20 1 4) .  The maj ority of these above 
publ ications, except two on Klebsiella pneumoniae from Tunisia (Ktari et al .  2006) 
- 89 -
and from Hungary (Melegh et a1 .  20 1 4), and a further one on E. cloacae also from 
Hungary (Juhasz et al . 20 1 2) report clonaIl unrelated or sporadic occurrence of 
VI M-4 producer Enlerobacteriacae. 
It is noteworthy, that our study pro ed the presence of V IM-4 producer E. 
cloacae in all the four countries investigated, even though the prevalence of such 
isolates was low. The only two isolates exhibiting sign ificant similarity by PFGE 
were isolated from the same hospital in Oman (OM63 and OM69). The isolates from 
the different countries were clonally unrelated when relatedness was investigated by 
PFGE; however, the two iso lates from Oman (OM63 and OM69) and the one from 
the UAE (ABC 1 04) carried the blavfM-4 on different plasmids but not identical 
integrons shared the sequence type. This suggests that applying the newly developed 
MLST scheme for E. cloacae complex may identify further relatedness of multi-drug 
resistant E. cloacae. 
Since the MLST scheme was only developed in 20 1 3  it is difficult to compare 
the c lonal relatedness of V IM-4 producing E. cloacae reported earlier to the ones 
studied in the thesis. However, the plasmid carrying the c lass I integron, as wel l  as 
the integrons themselves, can be compared to the ones reported earl ier (TABLE 1 7.) .  
Except for SA4/2, none of the blavfM-4 bearing plasmids in our E. cloacae 
i solates were conj ugative, unlike the ones reported earl ier. Furthermore most of them 
were untypable by the extended PBRT used, with the exception of the IncAiC type 
- 90 -
hlaYI 1-4-bearing pIa mid of ABC l 04. blaVI 1-1 bearing pJasrnids of clonal ly unrelated 
strains had different size with the exception of A4/2 and the OM63, OM69 pair of 
strain , carried simi lar sized, but PBRT untypable blaYIM-4 bearing episomes. 
Class I integron carrying blaYIM-4 in E. cloacae KW3 isolated in Kuwait was 
identical to In4 1 6  identi fied in I tal . E. cloacae SA4/2 from Saudi Arabia and 
ABC 1 04 from the UAE harbored a very similar integron as wel l ,  but the integron in 
these trains possessed the usual 3 '  -CS downstream of the I SPa2 1 .  The c lonal ly 
related Omani isolates (OM63 and OM69) carried the blaYTM-4 on c lass I integron 
very simi lar to thi latter one, albeit with the lack of gene cassettes of dfrA l and 
L1aadA l (TABLE 1 7.) .  
In summary, V IM-4 producer E. cloacae isolates with similar, but not 
identical, genetic features were present in low prevalence in al l  of the four countries 
invest igated. 
Contrary to V IM-4 producer, E. cloacae, K. pneumoniae isolates carrying 
VIM-4 was present in  Kuwait only. Earl ier, in the 1 990s and early 2000, K. 
pneumoniae became the index species for plasmids encoding extended-spectrurn­
beta- lactamases (ESBLs), along with a variety of genes conferring resistance to drugs 
other than �-lac tams (Tzouvelekis et a l .  20 1 2), so it is interesting to note that Kuwait 
had the highest inc idence of VIM-producer Enterobacteriaceae (29 .6%), which was a 
c lear difference between this country and the other three investigated in this study. 
- 9 1  -
Of the si strains, only two, KW 1 and KW2, were clonal ly related by PFGE 
and MLST harboring a unique sequence type ST 1 399. Another two strains KW4 
( T 1 3  8)  and KW 6 CST 1 400) belonged to other sequence types not related to any 
clonal complex. evertheless, two of the six strains belonged to international 
epidemic clones of K pneumoniae, KW l l to ST 1 47 and KW8 to CC 1 8  CST 1 40 1  is a 
single locus valiant of T 1 8) .  Both of these clones contributed to the epidemic of 
VIM-producer K. pneumoniae in Greece (Hasan et al .  20 1 4) .  Furthermore, K. 
pneumoniae ST 1 47 was associated with a small hospital outbreak caused by NDM- l 
producer K pneumoniae in China (Wang et al .  20 1 3 ) and it is one of the highly 
successful enterobacterial clones spreading CTX-M-type �-lactarnases worldwide 
(D'Andrea et al. 20 1 3 ) .  
Al l  V IM-4 producer K pneumonia, with the exception of  KW 1 1 ,  carried the 
gene on an I ncAiC plasmid also harboring blacMY-4, which had a size of 1 75kb and 
was conj ugative in five of the six isolates. Furthermore, al l  six strains carried blavTM-4 
on simi lar structured c lass 1 integrons (1n4 1 6) .  These data, together with the fact that 
the same size and incompatibi l i ty group plasmid with In4 1 6  was found in the single 
E. coli KW7 isolate also from Kuwait, suggest of a successful plasmid spread in  this 
geographical location. Moreover, the I n4 1 6  or similar integron located on conjugative 
p lasmids, which belonged to IncAie when tested, was reported earlier from I taly 
spreading between E. cloacae and K. pneumoniae (Luzzaro et al .  2004) and from an 
outbreak in Tunisia (Ktari et al. 2006) indicates the dissemination capacity of this 
- 9 2  -
genetic lructure carrymg blaVI 1-4 and blacMY-4 (TABLE 1 8. Integration of this 
episome into successfully preading MDR clones of K. pneumoniae i .e .  T 1 47 and 
1 8 . is a phenomenon, hich warrants not only strict  infection control measures, 
but c lose monitoring by active survei l lance in order to avoid a scenario as emerged in 
Greece (Ha an et al .  20 1 4) or in Hungary (Melegh et al .  20 1 4). 
As far a non-carbapenem susceptibil ity v as concerned the majority of the 1 2  
i olate possessed addit ional �- lactamases and plasmid-mediated quinolone resistant 
determinant and were susceptible to few antibiotics only, thus fulfi l l ing the multi­
drug resist criteria et by (Magiorakos et al .  20 1 2) .  Moreover, K pneumoniae KW l l 
was almost pan-resistant, i .e .  resistant to colistin and tigecyc l ine and only 
intermediate susceptible to amikacin.  Considering that this isolate is a member of the 
ST 1 47 MDR c lone of K pneumoniae, further emphasizes the need for active 
interventions to stop the spread of such organisms. 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































V I .  CONC L U S I O N S  
• VIM-producer Enterobacteriaceae are present in the Arabian Peninsula, although 
th ir pre alence among carbapenemase producers is low in audi Arabia, Oman 
and the UAE. 
• 1 1  V I M-producer Enterobacteriaceae investigated in this study carried the V IM-4 
type, hich i more effic ient in hydrolyzing the carbapenems than the VIM- l 
endemic in Greece and I taly. 
• VI M-4 producer Enterobacter cloacae carrying the blavfM-4 on similar, but not 
identical genetic structures were isolated in all four countries investigated. 
• The blavfM-4 bearing c lass I integron structures identified in the study are simi lar to 
tho e reported from North Africa and I taly suggesting the possibil ity of the spread 
these resistance genes from the Mediterranean region to the Gulf. 
• The high incidence of V IM-producer Enterobacteriaceae encountered in Kuwait 
was not due to the c lonal spread of a strain, but most probably the result of 
spreading of an I ncAiC plasmid, co-harboring blavfM -4 and blacMY-4, into Klebsiella 
pneumoniae and E. coli. 
- 9 6 -
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